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ABSTRACT 
Post-synthesis DNA modification is a very useful method for DNA functionalization. 
This is achieved by using a modified NTP, which has a handle for further modifications, 
replacing the corresponding natural NTP in polymerase-catalyzed DNA synthesis. Subsequently, 
the handle can be used for further functionalization, preferably through a very fast reaction. 
Herein we describe polymerase-mediated incorporation of trans-cyclooctene modified thymidine 
triphosphate (TCO-TTP). Subsequently, the trans-cyclooctene group was reacted with a tetrazine 
tethered to other functional groups through a very fast click reaction. The utility of this DNA 
functionalization method was demonstrated with the incorporation of a boronic acid group and a 
fluorophore. The same approach was also successfully used in modifying a known aptamer for 
fluorescent labeling applications. Boronic acid modified DNA molecules were further applied in 
aptamer selection for cancer cell recognition.  
The second project was focused on developing fluorescent probes/sensors for biothiols. 
Because of the biological relevance of thiols and sulfides such as cysteine, homocysteine and 
hydrogen sulfide, their detection has attracted a great deal of research interest. Fluorescent 
probes are emerging as a new strategy for thiol and hydrogen sulfide analysis due to their high 
sensitivity, low cost, and ability to detect and image thiols in biological samples. A sulfonyl 
azide-based fluorescent probe has been developed for the quantitative detection of H2S in 
aqueous media such as phosphate buffer and bovine serum. In addition, another novel 
fluorescent probe has been developed for the detection of homocysteine. The fluorescence 
response is selective for homocysteine over other biologically abundant thiols such as cysteine 
and glutathione. In addition, a linear calibration curve was also be obtained for quantitative 
analysis in phosphate buffer and plasma. These selective fluorescent probes could be very useful 
tool for biothiol tests.  
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1 
1 DEVELOPMENT OF BORONIC ACID-MODIFIED NUCLEOSIDE 
TRIPHOSPHATE FOR DIAGNOSTIC APPLICATIONS 
1.1 Introduction  
1.1.1 DNA modification methods 
 Beyond its natural functions as genetic codes, the utility of DNA in sensing,1-2 new 
structural scaffolds,3 therapeutics,4-6 and in vitro aptamer selections7-9 have been well-
established. As such, modified DNA molecules are often used because of the possibility of 
endowing additional structural and spectroscopic properties, which allow for enhanced functions 
and detection.10-11 Thus DNA modification has been a very active field of research; and several 
excellent results on DNA modification methods and applications by were reviewed.12-14  
As a historical background, using modified nucleosides for biological incorporation and 
their various applications are far from a new thing, although recent interest levels are very high. 
Tritiated ([3H]) thymidine autoradiography was firstly introduced in the late 1950’s and served as 
a powerful technique for studying cell proliferation in situ for decades.15-19 Later, less time-
consuming strategies that do not rely on radioactive materials were developed to study cell 
proliferation and neurogenesis.19 For example, many halogenated thymidine analogs such as 
BrdU, CldU, or IdU (Figure 1.1) 19-20 were developed as alternative labeling methods. BrdU is 
currently the most commonly used metabolic label and has been widely used in areas such as cell 
proliferation and neurogenesis.19, 21-22 In such an application, an antibody against BrdU is used to 
detect incorporation levels. However, harsh chemical denaturation conditions needed for 
processing the cellular DNA and poor tissue penetration of the BrdU antibody limit the utility of 
BrdU.23 Especially important is the fact that these methods do not allow for studying live cells. 
In order to overcome limitations of existing methods, new chemistry is being developed. Such 
2 
new chemical strategies are bio-orthogonal, have a diverse set of structural properties for various 
applications, and allow for exploration of DNA in their native environments.24-32 Often these 
newer approaches involve the use of click chemistry.33-34 
 
Figure 1.1 Structures of BrdU, CldU and IdU 
 
In 2006, Seela35 and Carell36 firstly reported modifications of deoxynucleotides through 
copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC) reaction developed by Sharpless37 and 
Maldel.38 In the earlier cases, only a small modification such as an azide or a terminal alkyne is 
initially introduced, to make sure the structure and function of the biomolecules remain virtually 
unchanged.24-25 Later on, copper-free click chemistry was widely used in chemical biology 
applications,39-41 in order to avoid issues related to copper.42 Especially in DNA modification, 
several pieces of recent work including crossing-linking,43-44 biomolecules labeling,45-49 and 
cellular imaging50 have been published in this area. Different types of “clickable” analogues have 
been used for visualizing DNA synthesis through secondary functionalization via click 
chemistry. In such an approach, a synthetic label containing a bio-orthogonal functional group is 
metabolically incorporated into the cellular target and subsequently probed using a 
chemoselective reaction.  
Among all the nucleoside/tide modifications, which still allow for enzymatic recognition, 
modified thymidine analogs are probably the most commonly used. It has long been known that 
modification at the C5-position of deoxyuridine can be tolerated by various polymerases.51-52 In 
3 
addition to examples of modified nucleosides being incorporated into DNA in live cells; there 
have also been interests in developing modified nucleosides/tides for direct incorporation into 
DNA in enzymatic reactions. In such an approach the triphosphorylated nucleosides are needed 
for polymerase-mediated DNA synthesis. The modified residues have to be recognized by 
polymerase and also be stable under primer extension and PCR conditions. An often-used 
strategy is to first modify the nucleoside with a handle that (1) is tolerated by DNA polymerases 
and (2) can be used to introduce additional functional groups after DNA synthesis.14, 53-54  
There are several publications reported strain-promoted alkyne–azide cycloaddition 
(SPAAC) reaction being applied in nucleic acids labeling55-56 and DNA ligation.57 The Brown 
group reported ligation work57 and DNA cross-linking using dibenzocyclooctyne (DIBO) and 
bicyclo [6.1.0] non-4-yne (BCN) modified phosphoramidite for chemical synthesis of modified 
DNA.58 Recently, the same group reported successful enzymatic incorporation and labeling 
using DIBO and BCN modified triphosphates through primer extension (Figure 1.2).59 
 
Figure 1.2 Structures of BCN and DIBO modified TTP 
 
In addition to the C5-position of deoxyuridine, the C8-position of deoxyguanosine is 
another common site for DNA modification.60 Earlier work was focused on chemical synthesis 
and applications in studying oligonucleotides’ conformation and investigating DNA 
hybridization.61-63 In 2012, Diederichsen and coworkers firstly developed a chemically 
4 
synthesized fluorescent 8-vinyl-2’-deoxyguanosine (VdGTP, Figure 1.3, compound 6) modified 
DNA for topology exploration.64-65 Enzymatic synthesis of VdGTP-modified DNA was also 
reported in the same year.66 There are other 8-styryl-2’-deoxyguanosine (SdGTP, Figure 1.3, 
compound 7) modified DNA reported, which focuses on its unique photochemically reversible 
isomerization potential.67 Experiments showed that these guanosine derivatives had no or 
minimal effect on the B-form structure of DNA. 
 
Figure 1.3 Structures of modified GTP 
 
Among the different modification sites of nucleosides, deoxyadenine modification and 
enzymatic fluorescent labeling were also examined. As discussed above, inverse electron 
demand Diels–Alder (IEDDA) has been applied in DNA modifications because of its reaction 
rate and bio-compatibly. Marx and co-worker reported vinyl-modified DNA and its labeling 
using IEDDA in 2014.68 7-vinyl-7-deaza-2’-deoxyadenosine (dvinA) and 5-vinyl-2’-deoxyuridine 
(dvinU) were synthesized following a known procedure69 for further enzymatic incorporation and 
post-synthesis labeling. 
Hocek’s group reported a fluorophore-labeled nucleotide, dNAPI (or DAPI)TP (Figure 1.4, 
compound 8, 9)70 for DNA-protein interaction studies in 2012. In further studies of DNA-protein 
interaction using fluorophore-labeled DNA molecules, Hocek and co-workers designed and 
synthesized a GFP-like fluorophore-labeled DNA.71 Specifically, 4-hydroxy-
benzylideneimidazolinone (HBI) is a fluorophore in GFP,72-73 which shows weak fluorescence as 
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a free molecule form in denatured protein.74 The fluorescence of HBI can be significantly 
increased by restricting its conformational freedom, as is in the situation of binding to a 
protein.75 Developed from previous reported work on HBI linked with RNA,75 3,5-difluoro-4-
hydroxybenzylideneimidazolinone (FBI) and 3,5-bis(methoxy)-4-hydroxybenzylideneimidazo-
linone (MBI) were conjugated with cytosine triphosphate (CTP) to label DNA molecules (Figure 
1.4, compound 10, 11).71 
 
Figure 1.4 Structures of (D)API and M/FBI modified CTP 
 
From the examples above, it is clear that modifications on the nucleobase of 
deoxynucleoside triphosphates allow for the creation of very useful probes in studying DNA 
replication and binding with proteins. Conceivably, sugar modifications represent possibilities. 
However, the deoxyribose portion does not have many positions that allow for modification 
without fundamentally changing its properties. The only position, which might allow for the 
modification with halogenation such as “fluorination” and the introduction of a protected 
hydroxyl group, is the 2’-position. Those with a free 2’-hydroxy group have similar structures 
with RNA monomers, and are hardly recognized by DNA polymerase.76 In 2009, Wagenknecht 
and coworkers reported the chemical synthesis of sugar modification site on 2’-O position of 
ribose.77 In 2013, the same group reported enzymatic synthesis and fluorescent labeling of 2’-O-
propargyl-TTP.78 This RNA-type 2’-O-propargyl nucleoside triphosphate (pNTP, Figure 1.5, 
6 
compound 12) is recognized by DNA polymerase and forms duplex structures with its 
complementary sequences. 
 
Figure 1.5 Structure of pNTP 
 
There have been other sites modifications, like backbone modifications that use chemical 
synthesis instead of enzymatic incorporations.79-80 They will be very useful as well. In addition to 
enzymatic incorporation of modified nucleotides into DNA, a number of chemical syntheses of 
modified DNA have been published. For example, Wagenknecht’s group published work on 
post-synthetic fluorophore labeling using copper-free click81 and photoclick reactions.82 
Diederichsen and coworkers have developed a fluorescent DNA probe, 8-vinyl-2’-
deoxyguanosine, and applied it in DNA structural studies64 and peptide nucleic acid (PNA) 
building blocks.65 Such work has been reviewed recently, and thus is not discussed in detail.12, 14, 
53-54 
Aptamers are mostly single strands of oligonucleotides capable of binding to the intended 
targets7-9 from small molecules to living cells with high affinity and specificity.83-84 It have been 
recognized as useful tools in developing diagnostic and therapeutic agents.85-86 Their diverse 
three-dimensional structures provide the possibility for developing aptamer-based molecular 
probes that are able to recognize biomarkers of great clinical diagnostic value.87 In recent years, 
cell-based systematic evolution of ligands by exponential enrichment (cell-SELEX) has been 
extensively used to select aptamer candidates, which can distinguish the cell type of interest, or 
recognize the biomarkers of interest on cell surface.88-91 The aptamer candidates go through 
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partitioning and will be remained on the target cell due to their higher binding affinity to the 
target. The surviving candidates can be collected and amplified by PCR and further go through 
several rounds of partitioning. Thus, the sequences with high binding affinity are enriched in the 
process of SELEX. However, the cell-SELEX method is usually involving a number of 
cumbersome steps and lack of efficiency. Usually, aptamers can be selected from all natural 
DNA/RNA pool. However, modifications with appropriate functional groups could endow these 
aptamers with special properties for enhanced affinity and/or selectivity. Recently, 
Krishnakumar’s group reported an aptamer with fluorophore modification, which can recognize 
epithelial cell adhesion molecule (EpCAM).92 Specifically, the EpCAM aptamer sequence 
SYL3C93 with a terminal azido group can be conjugated to Alexa-fluor 594 (AF594) with a 
DIBO handle. Such modified aptamer was used in cell labeling studies. Flow cytometry analysis 
demonstrated successful labeling and obvious fluorescence improvement. Further live cell 
incubation and imaging was conducted using MCF7 (high EpCAM expression), Weri-RB1 
(moderate EpCAM expression) and MIO-M1 (low EpCAM expression) cells. The aptamer 
fluorescence can be visualized and measured by fluorescent microscopy and flow cytometry. The 
mean fluorescence intensity (MFI) of the total population correlated with different cell line 
EpCAM expression. Cytotoxicity of EpDNA-DIBO-AF594 was also explored with various cells. 
No significant toxicity was observed at 1 µM after 48 h incubation. This is yet another example 
of the usefulness of DNA modification. 
1.1.2 Boronic acid-based chemosensors and applications in DNA modification 
Boronic acid is known as one of the most common moieties in chemosensors design 
because of its affinity for diols,94-101 α-hydroxyl acids,102-103 α-aminoacids,104 aminoalcohols,105-
106 alcohols,107-109 even cyanide110-111 and fluoride.112-113 Especially after Czarnik114 and 
8 
Shinkai115 reported using boronic acids as chemosensors for diols in early 1990s’ (Scheme 1.1), 
the boronic acid group has been widely used as the building blocks of chemosensors targeting 
saccharides,95, 114, 116-120 carbohydrate transporters121-127 and affinitive ligands for affinity 
chromatography.128-130 Our group has been interested in using the boronic acid moiety for 
sensing applications, especially for carbohydrates chemosensors.97, 101, 118-120, 131-137 
 
Scheme 1.1 Binding equilibrium of phenylboronic acid with a diol 
 
Our group has had a long-standing interest in using the boronic acid moiety for various 
sensing applications.97, 131-132, 138 Along this line, we have been working on the incorporation of 
the boronic acid functional group into DNA for aptamer selection139-140 and other 
applications.141-144 In incorporating the boronic acid group into DNA, there are special 
considerations because of the hygroscopic properties and Lewis acidity of this functional group. 
We have recently demonstrated the feasibility of direct PCR incorporation of boronic acid-
modified TTP (Scheme 1.2, Route A)139 and post-PCR incorporation of the boronic acid group 
into DNA (Scheme 1.2, Routes B).142, 144 In post PCR DNA modification work, it is critical that 
the reaction goes to completion within a short period of time for various practical reasons. Thus 
it would be desirable to use click reactions that are fast enough so that completion of the reaction 
is assured on the scale of minutes. With most of the DNA click-modification reactions reported, 
9 
one fast condensation reaction of 1, 2-aminothiol with 2-cyanobenzothiazole (CBT) has a 
second-order rate constant of 22 M-1·s-1.48, 144 This means that at 1 µM, the reaction’s first half-
life (t1/2) would be more than 12 h. One would have to force the reaction by increasing the 
concentration of the non-DNA click partner agent because the concentrations of the DNA 
product from PCR amplifications are limited by PCR efficiency at high concentrations and 
primer concentrations, and are generally in the low µM range. Even under forcing conditions, it 
would still take hours for the reaction to go to completion. Thus, we set out to develop 
modification chemistry, which would give a shorter half-life. Tetrazine-trans-cyclooctene 
cycloaddition is recognized as one of the fastest click reactions, with second-order rate constant 
being up to 22000 M-1·s-1, which would give a first half-life of 45 second at 1 µM 
concentration.40, 141, 145-147 Thus in this study, we examined the feasibility of using the tetrazine-
trans-cyclooctene chemistry for the post-PCR labeling of DNA with the boronic acid moiety 
(Route C, Scheme 1.2). 
10 
 
Scheme 1.2 A schematic representation of strategies for DNA modifications with a boronic acid 
A). Enzymatic incorporation of boronic acid-modified nucleotides; B). Enzymatic incorporation 
of CBT modified nucleotides, followed by post-PCR modification; C). Enzymatic incorporation 
of trans-cyclooctene modified nucleotides, followed by Cu-free post-PCR modification 
 
1.1.3 Cell-based SELEX 
Following the research on TCO-TTP incorporation into DNA molecules and subsequent 
boronic acid labeling, we preceded with cell-based SELEX to select aptamers targeting 
glycoproteins on the cell surface. We developed boronic acid-modified aptamers that target 
mucin 13 (MUC13), a transmembrane glycoprotein expressed in a variety of epithelial 
carcinomas. Mucin proteins are known for its protection and lubrication effect on the epithelial 
surfaces.148 Mucin 13, a transmembrane type of mucin, has been implicated in cancer 
development based on laboratory findings of a malignant phenotype of MUC13-transfected cell 
11 
lines.149-150 Thus, mucin 13 is a potential early marker of epithelial cancer and a promising target 
for anti-cancer drug delivery. In this study, we used HPAF II, a pancreatic cancer cell line that 
highly expresses MUC13 as our selection target in the cell-SELEX. Another pancreatic cancer 
MUC13-null cell line, MIA Paca, was used as a control cell line in the selection process. 
1.2 Results and discussion 
1.2.1 Synthesis of TCO-TTP 
It has long been demonstrated that modification at the C5-position of deoxyuridine can be 
tolerated by various polymerases and such modified nucleotide triphosphates can be incorporated 
as a thymidine surrogate into DNA.51-52  Thus we chose to install a click handle at the C5-
position of deoxyuridine for further modifications. The trans-cyclooctene moiety can be 
introduced into compound 21 using amidation chemistry.151 Then subsequent triphosphorylation 
followed a one-pot three-step method152 to generate the final compound trans-cyclooctene 
triphosphate (6) in 32 % yield (Scheme 1.3). 
12 
 
Scheme 1.3 Synthesis of trans-cyclooctene-modified deoxyuridine/thymidine triphosphate 
 
1.2.2 Thermo-stability Studies of trans-Cyclooctene 
Before PCR incorporation studies, we examined the stability of trans-cyclooctene 
modified nucleotide at high temperature using NMR and HPLC. To investigate trans-
cyclooctene stability at high temperature, trans-cyclooctene sample was dissolved and heated in 
DMSO-d6 at 90 oC. NMR spectra were scanned and recorded every 10 min to observe the 
isomerization from trans-isomer to cis-isomer. Isomerization percentage was calculated based on 
peak area of the peak at δ 5.55 ppm. Compared to the cis-cycloocetene peak, only 2% and 10% 
of trans-cyclooctene changed to the cis-isomer after heating at 90 oC for 20 min and 70 min 
(Figure 1.6). In addition to the NMR studies, TCO thermo-stability was further examined with 
HPLC. As shown in Figure 1.7, there was no noticeable difference after heating the TCO at 90 
oC for 20 min (Figure 1.7C). After heating at 90 oC for 70 min, almost 20% of TCO underwent 
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1.2.3 Enzymatic incorporation and post-synthesis labeling of TCO-TTP 
To study whether the modified nucleotide 28 can be recognized by a polymerase, we first 
incorporated trans-cyclooctene thymidine triphosphate (TCO-TTP) into a short DNA via primer 
extension using the Klenow fragment-catalyzed reaction. Based on previous successful 
incorporation studies,141, 144 we used a 21-mer oligonucleotide (nt) template-1 (5’-GGT TCC 
ACC AGC AAC CCG CTA-3’), a 14-mer primer (5’-TAG CGG GTT GCT GG-3’) for the 
primer extension work (See experimental section for details). The template and primer were 
designed in such a way that the first incorporated nucleotide would be a T. Thus if TCO-TTP 
cannot be successfully recognized by the polymerase, there would be no primer extension. The 
extension products were examined by polyacrylamide gel electrophoresis (PAGE) (Figure 1.8). 
The experiments included several negative controls: (1) primer extension with all the necessary 
components except TTP (Lane 1, Figure 1.8A) (This is to make sure that enzyme fidelity would 
not be an issue and mis-matched incorporation does not happen), (2) primer extension with all 
the necessary components except the enzyme (Lane 2, Figure 1.8A), (3) primer extension only in 
the presence of the template and primer without the dNTPs and the enzyme (Lane 3, Figure 
1.8A), and (4) primer only without the other necessary components (enzyme, template, and 
dNTPs) (Lane 4, Figure 1.8A). Positive control was Klenow fragment catalyzed primer 
extension using natural dNTPs (Lane 5, Figure 1.8A). TCO-TTP incorporation product was 
studied under Klenow fragment catalysis (Lane 6, Figure 1.8A). , It is clear that primer extension 
with all natural dNTPs (Lane 5) and TCO-TTP (Lane 6) showed similar full-length double 
stranded DNA bands, demonstrating successful incorporation of TCO-TTP. Next, we wanted to 
explore the feasibility of post-PCR modification with the incorporation of a boronic acid. Thus, 
tetrazine-bisboronic acid (Tz-BBA, Figure 1.8C) was synthesized for click-modification of the 
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and Appendix) showed a molecular ion of m/z 7237.6 (calculated: 7238.6, [M+ Na+]). The 
primer extension product using dNTPs was also reacted with Tz-BBA (Lane 4, Figure 1.8B). 
The product gave a molecular ion of m/z of 6520.0 (calculated: 6519.3, [M+ H+]), which is the 
same as the original extension product, suggesting no reaction with Tz-BBA, as one would have 
expected. The mass spectrometric results further support the successful incorporation of one 
TCO-TTP moiety into DNA molecule and boronic acid labeling of DNA. 
To further explore the feasibility of incorporating multiple TCO-TTP into DNA, we 
designed two more 21-mer templates complementary to the same 14-mer primer, template-2 (5’-
TCA GTC ACC AGC AAC CCG CTA-3’) and template-3 (5’-CAC GAC ACC AGC AAC 
CCG CTA-3’). These templates contained 2 or 3 A in the sequence, respectively, that can 
incorporate 2 or 3 TCO-TTP moieties into DNA. Based on previous optimization work using the 
Klenow fragment,144 incorporation of additional modified TTP required higher temperature and 
longer incubation time than incorporating a single modified TTP. Under harsh conditions, 
Klenow fragment catalysis would give incomplete extension products and several blunt bands on 
gel. As a result, we chose the KOD-XL DNA polymerase, a family B polymerase from 
thermococcus kodakaraensis, which is more tolerant of unnatural TTP.153 Analysis using 20% 
PAGE indicated successful primer extensions with the incorporation of both 2 and 3 Ts (Figure 
1.9). Template-1 primer extension using dNTPs (Lane 1, Figure 1.9A) was conducted as positive 
control. Primer extension products using TCO-TTP in place of dTTP were obtained with 
template-1 (Lane 2, Figure 1.9A), template-2 (Lane 3, Figure 1.9A) and template-3 (Lane 4, 
Figure 1.9A). As seen in Figure 2A, the electrophoretic mobility of primer extension products 
decreased progressively with increasing number of TCO-TTP moieties, indicating successful 
incorporation of multiple TCO-TTP units into DNA. To further confirm TCO-TTP’s 
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place of TTP, 3. Taq catalyzed PCR product using dNTPs, 4. Taq catalyzed PCR product using 
TCO-TTP in place of TTP; 5. Deep VentR catalyzed PCR product using dNTPs, 6. Deep VentR 
catalyzed PCR product using TCO-TTP in place of TTP. B). Post-PCR boronic acid labeling of 
amplified DNA product with TCO-TTP incorporation, 15% PAGE analysis: 1. PCR 
amplification in absence of TTP, 2. PCR amplification with dNTPs, 3. PCR amplification using 
TCO-TTP in place of TTP; 4. PCR amplification product using TCO-TTP reacted with Tz-BBA, 
5. PCR amplification product using dNTPs reacted with Tz-BBA. 
 
Encouraged by the results from TCO-TTP incorporation into a 90-nt DNA sequence and 
successful post-PCR boronic acid labeling, we further explored incorporating TCO-TTP into a 
published aptamer to see whether we can use the TCO-TTP handle for labeling DNA sequences 
with other structural moieties, such as fluorophore. N37 is a known aptamer selectively targeting 
the thrombospondin-1 (TSP-1) protein on the surface of inflamed endothelial cells with high 
potential of atherosclerosis.155-156 Using the same PCR amplification conditions described above, 
N37 was used as new template for amplifications. Tetrazine-FITC (fluorescein isothiocyanate 
reacting with an amino handle of tetrazine, Tz-FITC, Figure 1.11B) was synthesized for post-
PCR fluorescent labeling of TCO-TTP modified DNA. We studied the incorporation of 
fluorescein into a known aptamer155 N37 and the applicability of using such a fluorophore-
labeled DNA for binding applications. TCO-TTP modified N37 (TCO37) (Lane 3, Figure 1.11A) 
was obtained and analyzed with 15% PAGE after KOD-XL catalyzed PCR. This amplification 
product generated fluorescein-labeled N37 aptamer (Lane 4, Figure 1.11A) after reacting with 
Tz-FITC. Natural N37 aptamer (Lane 2, Figure 1.11A) was used as positive control. The product 
of N37 (generated using dNTPs) reacting with Tz-FITC (Lane 5, Figure 1.11A) was used as 
negative control for the fluorescein labeling experiments. As shown in Figure 4A, only the PCR 
product with the trans-cyclooctene moiety reacted with Tz-FITC as indicated by the fluorescent 
band (FITC channel, λem: 520 nm, Lane 4, Figure 1.11A). No fluorescence was detected in other 
lanes. E
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21 
conducted with cell only (Figure 1.12A) and N37 (no click handle) reacted with Tz-FITC (Figure 
5C). 4',6-Diamidino-2-phenylindole (DAPI) staining (for nuclei) was also used. Cells were 
examined using three channels (Figure 1.12): (1) DAPI channel (λem: 461 nm; first row) for 
nuclear staining; (2) FITC channel (λem: 520 nm, second row) for detecting the fluorescein 
signal; (3) phase contrast channel for morphological observations (third row); and (4) Merged 
channel, with images of DAPI, FITC and phase merged into one (fourth row). As one can see, all 
cells stained normally with DAPI and have normal morphology under phase contrast, indicating 
normal cell growth.  However, only the cells treated with FITC-labeled TCO37 aptamer showed 
significant fluorescent labeling in the fluorescein channel.  Interestingly, the FAM-N37 labeled 
cells did not show the same significant fluorescent labeling. The results so far indicate that 
replacing T with TCO-T in aptamer N37 didn’t affect its binding affinity to TSP-1 and allowed 
for fluorescent labeling of cells after the incorporation of a fluorophore. The ability to 
incorporate multiple fluorophores could provide enhanced sensitivity for labeling. Conceivably, 
the same approach can be used in other known aptamers for binding studies. 
22 
 
Figure 1.12 Images of Hela cells were taken using a confocal microscope. 
Fluorescent images of four samples were shown: A column: blank, cell only; B column: FAM-
N37 aptamer; C column: product of N37 aptamer reacting with Tz-FITC (negative control); D 
column: FITC-labeled TCO37 sequence. Images were taken with 3 channels: 1. DAPI channel 
(λem: 461 nm, first row); 2. FITC channel (λem: 520 nm, second row); 3. Phase contrast channel 
(third row); 4. Images from the DAPI channel merged that of the FITC channel and phase 
channel (fourth row) 
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HPAF II and MIA Paca cell lines were chosen to be the target and control cells 
respectively in the selection. HPAF II and MIA Paca are both human pancreatic cancer cell lines, 
which share many common features. However, one distinct difference between these two cell 
lines is that HPAF II highly expresses MUC13 but MIA Paca is a MUC13-null cell line.167 This 
makes them suitable for being a target cell line and a control cell line in the cell-SELEX 
selection. The single-stranded sequences pool selected from each round was amplified with 
FAM-labeled primer, which gave fluorescent sense ssDNA molecules. When the FAM-labeled 
sequences bound to glycoprotein on cell surface, it would show obvious fluorescence enrichment 
on cell surface under fluorescence microscope. Thus, binding of the selected sequence pool to 
the target cell and control cells was monitored by fluorescent imaging after each round.  
Starting from an initial 80-mer DNA pool, we synthesized ssDNA (4 µM), incorporated 
boronic acid groups and incubated with target cell HPAF II for 30 min at 37 ⁰C. After 
incubation, we discarded unbound sequences in buffer and collected cells that bound the target 
cells. Then we heated the cell suspension to release the bound ssDNA through protein 
denaturation. The sequences collected were used as the template in the next round PCR 
amplification. In order to maximize the number of sequences that survives at the beginning of 
selection, the first three rounds were performed without counter selection (no control cells 
involved). According to the fluorescent images, fluorescence on cell surface progressively 
increased with each round of selection, indicating that binding obviously increased after 3 rounds 
of selection (Figure 1.13), which seems to be more efficient compared with previous reports.168-
170 
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Figure 1.13 Fluorescent image of the first 3 selected pool binding to the target cell. 
The second raw is the phase contrast images of the first raw. (The boronic-acid modified 
sequences have a FAM fluorophore at the 5’ end. The selected pool after 3 rounds showed 
binding, which is indicated with a white arrow in the figure.) 
 
From the 4th round, the control cells were used in counter selections to remove the 
sequences that also bind to the control cells, as well as to increase the specificity of selection. 
Selected single-stranded sequences from the 3rd round were amplified with PCR and modified 
with boronic acids. These modified ssDNA was firstly incubated with control cells to remove 
sequences bound to MIA Paca, and followed by incubation with target cell line. As shown in 
Figure 1.14, after the counter selection was introduced, binding intensity decreased substantially, 
indicating a reduction in the number of sequences that bind to the target cells. Again, after three 
additional rounds of selection, the binding appeared at 7th round and could be observed obviously 
on cell surface (Figure 1.14). Analysis using 15% PAGE indicated successful incorporation of 
boronic acid in the selected sequences after the 7th round (Figure 1.15b). As seen in Figure 1.15b, 
the boronic acid-modified sequences (Lane 2) showed decreased electrophoretic mobility 
compared to non-click DNA molecules (Lane 1), presumably because of the presence of the 
boronic acid group and increased molecular weight and affinity to the gel matrix materials. 
These results further suggest the high efficiency of selection using boronic-acid modified 
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a. A schematic representation of boronic acid incorporated in DNA; b. 15% PAGE analysis of 
boronic acid-modified sequences collected from 7th round; c. 15% PAGE analysis of PCR 
product prepared for sequencing. 
 
1.2.5.2 Sequencing and binding results 
The selected DNA library was cloned into E. coli and sequenced (see experimental 
section for details). Next-generation (Nextgen) sequencing was also used to analyze the enriched 
library (Tables 1.1 and 1.2). The sequencing results were analyzed with sequence alignment. To 
avoid misinterpretation, any sequence with fewer than 70 nucleotides in the library was 
discarded. Interestingly, sequences randomly selected from colonies and those obtained from 
Nextgen sequencing showed several identical sequences (highlighted in red). The identical high 
abundance sequences were the major components in selected pool and were considered potential 
aptamer candidates. Furthermore, these results indicated that the selection and enrichment 
progress approached to the end point of selection. As the result, the three identical as well as the 
most abundant sequences (3UB2, 3B6, 7UB4) were examined as for binding studies. The 
binding affinity towards HPAF II and MIA Paca cell lines were analyzed by flow cytometry and 
calculated by measuring fluorescence per cell as increasing concentration of selected 
sequences.161 
 
Table 1.1 Sequencing results from cloning 
Name Sequence 
3B4 CCT TCG TTG TCT GCC TTC GTG ACC ATG TGA CTG CAG CAC CCA GAC GGC CGC CAC CCT TCA 
GAA TTC GCA CCA 
3B6 CCT TCG TTG TCT GCC TTC GTG GGC CGA GGC TGG GCG GCG GGC GCG GCC ATG TGG GGG GGG 
ACC CTT CAG AAT TCG CAC CA 
3UB2 CCT TCG TTG TCT GCC TTC GTG GGC CGG GTG GAC CGA GCA TAA GGC GGG GGA GGT GGC GGC 
ACC CTT CAG AAT TCG CAC CA 
28 
7UB4 CCT TCG TTG TCT GCC TTC GTA CCC CAC ACG AAC CCC GAC GCG CCC GGG CAT CCT GGC TGC 
ACC CTT CAG AAT TCG CAC CA 
7UB5 CCT TCG TTG TCT GCC TTC GTG CGC CGT GCA GAC GGT ACC CGA CCC CCG CCT CCG GCC ACC 
ACC CTT CAG AAT TCG CAC CA 
 
 
Table 1.2 Sequencing results from Nextgen sequencing 
Name Sequence Abundance 
3UB2 
CCT TCG TTG TCT GCC TTC GTG GGC CGG GTG GAC CGA GCA TAA GGC GGG GGA 
GGT GGC GGC ACC CTT CAG AAT TCG CAC CA 4.63% 
3B6 
CCT TCG TTG TCT GCC TTC GTG GGC CGA GGC TGG GCG GCG GGC GCG GCC ATG 
TGG GGG GGG ACC CTT CAG AAT TCG CAC CA 2.25% 
7UB4 
CCT TCG TTG TCT GCC TTC GTA CCC CAC ACG AAC CCC GAC GCG CCC GGG CAT 
CCT GGC TGC ACC CTT CAG AAT TCG CAC CA 0.70% 
Oligo4 
CCT TCG TTG TCT GCC TTC GTG GGC CGG GGT GGA CCG AGC ATA AGG CGG GGG 
AGG TGG CGG CAC CCT TCA GAA TTC GCA CCA 0.70% 
Oligo5 
CCT TCG TTG TCT GCC TTC GTG GGC CGG GTG GAC CGA ACA TAA GGC GGG GGA 
GGT GGC GGC ACC CTT CAG AAT TCG CAC CA 0.28% 
Oligo6 
CCT TCG TTG TCT GCC TTC GTG GGC CGA GGC TGG GCG GCG GGC GCG GCC ATG 
TGG GGT GGG ACC CTT CAG AAT TCG CAC CA 0.28% 
Oligo7 
CCT TCG TTG TCT GCC TTC GTG GGC CGA GGC TGG GCG GCG GGC GCG GCC ATG 
TGG GGG GGG GAC CCT TCA GAA TTC GCA CCA 0.28% 
 
To obtain sense ssDNA and control the concentration of single-stranded sequence for 
bind studies, lambda exonuclease digestion was used to remove antisense sequences.162 
Conceivably, enzyme digestion of phosphate-labeled sequences and followed by 10k cut-off 
filtration would gave more accurate concentration of single-stranded sequences of aptamer 
candidates compared to asymmetric PCR.166 Thus, the sequences were synthesized using 
phosphate-modified complementary template, FAM-labeled sense primer 1 and TCO-TTP 
through
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candidates. Taking the most abundant sequence 3UB2 as an example, four sets of experiments 
were included. Binding studies of boronic acid-modified aptamer candidate (3UB2-BBA, 
column 5, Figure 1.17) and non-click, TCO-modified aptamer candidate (3UB2, column 4, 
Figure 1.17) were expected to show good affinity, especially boronic acid modified sequences. 
Two control experiments were designed to confirm binding efficiency and specificity. Because 
of low PCR efficiency in incorporating modified thymidine, the selected aptamer candidates only 
had 3 thymidine nucleosides among 40-nt randomized sites. Thus one control sequence was AT-
rich sequence synthesized with natural nucleosides triphosphate (control sequence, column 2, 
Figure 1.17). Another control sequence (nT-3UB2, column 3, Figure 1.17) was the same 
sequence as aptamer candidate except using natural TTP instead of TCO-TTP. As shown in 
Figure 5, TCO-modified aptamer candidate 3UB2 (column 4) and boronic acid-modified aptamer 
candidate 3UB2-BBA (column 5) had obvious increased binding fluorescence peak starting at 
125 nM. The newly appearing fluorescence binding peak indicated up to 15% of cells were 
bound with FAM-labeled sequences. The binding peak fluorescence percentage increased to 
more than 90% at 500 nM of sequences binding, which demonstrated strong binding between 
aptamer candidates and target cells. Under the same conditions, control sequence (column 2) 
didn’t have obvious fluorescence increases compared to aptamer candidates.  These binding 
results confirmed that selected sequences would have binding affinity to target cells. Another 
control nT-3UB2 (column 3) also didn’t show high fluorescence intensity compared to aptamer 
candidates, which demonstrated only TCO-TTP incorporated DNA molecules have strong 
binding to HPAF II. Other aptamer candidates (3B6 and 7UB4) binding affinity were also tested 
under the same condition (Figure 1.18). The binding results indicated good binding affinity of 
aptamer candidates to target cells. Compared to the data above, 3UB2 had the highest binding 
affinity 
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of binding studies were conducted: 1. AT-rich control sequence (control sequence, column 2, 
Figure 1.19); 2. 3UB2 aptamer candidate using natural TTP instead of TCO-TTP (nT-3UB2, 
column 3, Figure 1.19); 3. TCO-TTP incorporated and non-click 3UB2 aptamer candidate 
(3UB2, column 4, Figure 1.19); 4. Boronic acid-incorporated 3UB2 aptamer candidate (3UB2-
BBA, column 5, Figure 1.19). As seen in Figure 1.19, the aptamer candidate didn’t show obvious 
binding peak and fluorescence increase with incubation of control cell up to 2 µM. The control 
cell binding studies indicated that the aptamer candidates had good specificity between two 
pancreatic cancer cell lines as expected, resulting in the capability to recognize and differentiate 
these two cancer cell lines. 
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affinity to carbohydrates. Although glucose is not as a good binder as fructose, in the presence of 
25 mM of glucose in the buffer, most of boronic acids would be saturated by glucose binding. As 
a result, it might be hard to select sequences that can bind differently to target cells with boronic 
acid-modified and TCO-TTP modified. The data above demonstrated that selected modified 
sequences are potential aptamers for pancreatic cancer cell recognition, the target MUC13. 
Further structural studies and target identification work need to be conducted. 
1.3 Experimental Section 
1.3.1 General Information 
Solvents and reagents were purchased from VWR International, Oakwood Product Inc., 
or Sigma-Aldrich Co. and used without purification unless specified otherwise. When necessary, 
solid reagents were dried under high vacuum. Reactions with compounds sensitive to air or 
moisture were performed under argon. Solvent mixtures are indicated as volume/volume ratios. 
Thin layer chromatography (TLC) was run on Sorbtech W/UV254 plates (0.25 mm thick), and 
visualized under UV-light. Flash chromatography was performed using Fluka silica gel 60 (mesh 
size: 0.040-0.063 mm) using a weight ratio of ca. 30:1 for silica gel over crude compound. 1H, 
13C, and 31P-NMR spectra were recorded on a Bruker Avance 400 spectrometer (400, 100, and 
166 MHz, respectively) in deuterated chloroform (CDCl3), methanol-d4 (CD3OD), and DMSO-d6 
with either tetramethylsilane (TMS) (0.00 ppm) or the NMR solvent as the internal reference. 
HPLC purification for trans-cyclooctene triphosphate (TCO-TTP) was carried out using a 
Shimadzu LC-20AT VP system with a Zobax C18 reversed-phase column (9.4 mm × 25 cm). 
The sample was eluted (3 mL/min) with buffer A (20 mM triethylammonium acetate, pH 6.9-
7.1) and buffer B (50% acetonitrile, 20 mM triethyl ammonium acetate) with the following: 0 
min 0% B; 20 min 20% B; 30 min 100% B; 38 min 100% B; 40 min 0% B; and 45 min 0% B.   
36 
DNA primers and templates were purchased from Integrated DNA Technologies. Klenow 
fragment (3’-5’ exo), Taq. DNA polymerase and Deep VentR (exo-) DNA polymerase were 
purchased from New England Biolabs. KOD-XL DNA polymerase was purchased from EMD 
Chemicals. Reaction buffers were used as provided. Reaction buffers were used as provided. 
SELEX binding buffer contained: 4.5 g/L glucose, 5 mM MgCl2, 100 mg/L yeast tRNA, 1g/L 
bovine serum albumin in phosphate-buffered saline.161 SELEX washing buffer components are: 
4.5 g/L glucose and 5 mM MgCl2 in phosphate-buffered saline.161 
HPAF II and MIA Paca cell lines were obtained from Dr. Subhash Chauhan’s lab 
(University of Tennessee, Health Science Center). Cells were grown in DMEM culture medium 
supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin. Fluorescent imaging 
was conducted using Zeiss fluorescent microscope. The Qiagen PCR cloning kit was obtained 
from Qiagen. The flow cytometer used is BD LSRFortessa. 
1.3.2 Experimental Procedure for the Synthesis of TCO-TTP 
Synthesis of (E)-Cyclooct-4-en-1-yl (2,5-dioxopyrrolidin-1-yl) carbonate 22: Compound 
22 was prepared starting from cyclooctadiene (17) in four steps following literature 
procedures.172 
Synthesis of 5-(3-Aminoprop-1-yn-1-yl)-1-((2R,4S,5R)-4-hydroxy-5 (hydroxyl-methyl) 
tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione 26: Compound 26 was synthesized starting 
from 5-odo-2’-deoxyuridine (23) in two steps following literature procedures.139, 173 
Synthesis of TCO-T, (E)-Cyclooct-4-en-1-yl(3-(1-((2R,4S,5R)-4-hydroxy-5-(hydro-
xylmethyl)tetrahydrofuran-2-yl) 2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)prop-2-yn-1-yl) car-
bamate 27: To a mixture of succimidyl ester 22 (134 mg, 0.5 mmol) and amine modified 
deoxyuridine 26 (168 mg, 0.6 mmol) in DMF 10 mL was added DIPEA (129 mg, 1 mmol). The 
37 
reaction mixture was wrapped in foil and stirred in r.t. for 12 h. Reaction solution was 
concentrated under reduced pressure and purified with silica gel chromatography (12% MeOH in 
DCM) to give a white solid (108 mg, yield 52%).  1H NMR (methanol-d4): 8.25 (s, 1H), 6.25 (t, 
J = 6.4 Hz, 1H), 5.58-6.20 (m, 1H), 5.47-5.57 (m, 1H), 4.05 (s, 2H), 3.95-3.81 (m, 1H), 3.73-
3.77 (m, 2H), 3.24-3.37 (m, 2H), 2.26-2.37 (m, 4H), 2.21-2.25 (m, 1H), 1.99-2.00 (m, 4H), 1.93-
1.98 (m, 2H). 13C NMR (methanol-d4): 163.1, 149.8, 144.0, 134.7, 132.4, 128.4, 98.6, HRMS 
(ESI) for C21H27N3O7 [M+H]+ Cacld: 434.1849; Found: 434.1899.  
Synthesis of TCO-TTP, (E)-Cyclooct-4-en-1-yl(3-(1-((2R,4S,5R)-4-hydroxy-5-(((hydro-
xyl((hydroxy(phosphonooxy)phosphoryl)oxy)phosphoryl)oxy)methyl)tetrahydrofuran-2-yl)-2,4-
dioxo-1,2,3,4-tetrahydropyrimi-din-5-yl)prop-2-yn-1-yl)carbamate 28: To a solution of TCO-T 
26 (69 mg, 0.16 mmol) and proton sponge (42 mg, 0.19 mmol, pre-dried in vacuum over P2O5 
overnight) in anhydrous trimethylphosphate (0.6 mL) was added freshly distilled POCl3 (18 µL, 
0.19 mmol) dissolved in anhydrous trimethylphosphate (0.2 mL) dropwise via a syringe with 
stirring under argon at 0 °C. The reaction mixture was further stirred in an ice-bath for 2 h and 
then a solution of tributylammonium pyrophosphate (226 mg, 0.48 mmol) and tri-n-butylamine 
(0.4 mL,) in 1.0 mL of anhydrous DMF was added in one portion. The mixture was stirred at RT 
for 10 min and then triethylammonium bicarbonate solution (0.1 M, pH 8, 11 mL) was added. 
After stirring at r.t. for an additional 1 h, the resulting reaction mixture was transferred to a 50-
mL centrifuge tube. Then EtOH (33 mL) was added followed by 3 M NaCl solution (1.0 mL). 
After vortexing for 10 sec, the centrifuge tube was placed at -80 oC for 1 h, and then centrifuged 
at 5000 rpm for 20 min. After removing the supernatant, the resulting pellet was purified by 
HPLC and lyophilized to give a pale white powder (32 mg, 32%). 1H NMR (D2O): 8.06 (s, 1H), 
6.18 (t, J = 6.8 Hz, 1H), 5.58-6.20 (m, 1H), 5.47-5.57 (m, 1H), 4.16-4.25 (m, 2H), 4.08-4.12 (m, 
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3H), 4.0 (d, J = 7.2 Hz, 1H), 2.25-2.34 (m, 5H), 1.88-1.98 (m, 3H), 1.35-1.86 (m, 4H). 13C NMR 
(D2O):179.7, 164.6, 158.0, 150.0, 144.8, 135.6, 133.4, 99.2, 82.4, 73.2, 70.5, 65.3, 46.6, 40.4, 
38.7, 37.8, 33.7, 32.0, 30.6, 22.2, 8.2; 31P NMR (D2O) -10.9, -11.6, -23.3. MS (ESI) for 
C21H30N3O16P3 [M-H]- Cacld. 672.08; Found: 672.1  
1.3.3 Experimental Procedure for the Synthesis of Tz-BBA 
Synthesis of 4,4'-(1,2,4,5-tetrazine-3,6-diyl)diphenol: Compound was prepared starting 
from 4-hydroxybenzonitrile in two steps following literature procedures.174  
Syntheis of Tz-BBA (29): To a solution of diphenol compound (133 mg, 0.5 mmol) was 
added 4-(bromomethyl) phenylboronic acid (219 mg, 1.3 mmol), CsCO3 (488 mg, 1.5 mmol), 
and NaI (30 mg, 0.2 mmol) in acetone (20 mL). The mixture was heated to reflux and stirred at 
56 oC overnight. The solution was concentrated under vacuum and acidified with 1M HCl. The 
residue was washed with EtOAc and MeOH to afford Tz-BBA 29. 1H NMR (DMSO-d6): 8.47 
(d, J = 8 Hz, 4H), 7.83 (d, J = 8 Hz, 4H), 7.46 (d, J = 8 Hz, 4H), 7.31 (d, J = 8 Hz, 4H), and 5.28 
(s, 4H). HRMS (ESI) for C28H24B2N4O6 [M+H]+ Cacld: 534.1882; Found: 535.1965. 
1.3.4 Experimental Procedure for the Synthesis of Tz-FITC 
Synthesis of 2,5-Dioxopyrrolidin-1-yl 4-(6-(pyrimidin-2-yl)-1,2,4,5-tetrazin-3-yl) 
benzoate: Compound was prepared starting from pyrimidine-5-carbonitrile in three steps 
following literature procedures.175  
Synthesis of 5-(3-(2-Aminoethyl)thioureido)-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl) 
benzoic acid: Compound was prepared starting from commercially available fluorescein 
isothiocyanate (FITC) in one step following literature procedures.176 
Synthesis of Tz-FITC (30): To a mixture of tetrazine benzoate compound  (188 mg, 0.5 
mmol) and FITC compound  (112 mg, 0.25 mmol) in MeOH (20 mL) was added Et3N (55 mg, 
39 
0.5 mmol). The mixture was stirred at r.t. overnight. The reaction mixture was acidified to pH 2 
and extracted with DCM. Residue was concentrated in vacuo and purified with silica gel 
chromatography (20% MeOH in DCM) to give solid product with 40% yield. 1H NMR (DMSO-
d6): 10.42 (s, 1 H), 9.21 (d, J = 4.8, 2 H), 8.97 (s, 1 H), 8.67 (d, J = 8.2, 2 H), 8.48 (br, 1 H), 8.30 
(s, 1 H), 8.21 (d, J = 8.2, 2 H), 7.85 (t, J = 4.8, 1 H), 7.80 (d, J = 7.9, 1 H), 7.18 (d, J = 8.4, 1 H), 
6.69 (s, 2 H), 6.59 (m, 4 H), 3.78 (s, 2 H). HRMS (ESI) for C36H25N9O6S [M-H]- Cacld: 
710.1549; Found: 710.1589. 
1.3.5 Studies of the reaction kinetics between TCO-TTP and Tetrazine 
1.3.5.1 Study of reaction kinetics between TCO-TTP and 4-(6-(pyrimidin-2-yl)-1,2,4,5-
tetrazin-3-yl) benzoic acid 
To a solution of TCO-TTP in H2O was added a solution of 4-(6-(pyrimidin-2-yl)-1,2,4,5-
tetrazin-3-yl)benzoic acid (31, Tz-pym, core structure of Tz-FITC) aqueous solution to afford a 
final concentration of 20, 25, 30, and 40 μM for TCO-TTP, and a final concentration of 2 μM for 
Tz-pym. The resulting mixture was examined by monitoring its absorption at 327 nm. Using 
established procedures,147 the second-order rate constant was determined to be 1087 M-1.s-1. 
 
Scheme 1.5 Reaction between TCO-TTP and Tz-pym 
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dTTP, or TCO-TTP (200 µM). Reactions were performed by incubating the prepared solutions at 
90 oC for 1 min, 20 oC for 1 min, and 66 oC for 20 min. The primer extension products were 
analyzed by 20 % PAGE. 
1.3.6.3 Experimental Procedure for Post-synthesis Labeling of Primer Extension Products 
with Tz-BBA: 
The primer extension product TCO-DNA21 was purified using Millipore Amicon 3 kDa 
spin column. 2 μL of 10 mM Tz-BBA in DMSO was added into pre-purified TCO-DNA21 (20 
μL). The reaction was allowed to vortex at r.t. for 15 min. The negative control experiment was 
performed following the same procedure except using dNTPs-DNA21, the primer extension 
product using dNTPs and other reagents. The resulting DNA products after post-synthesis 
modification were purified with Millipore Amicon 3 kDa spin column and analyzed by 20 % 
PAGE. 
1.3.6.4 Experimental Procedure for PCR Incorporation and Post-PCR Labeling of TCO-
TTP: 
A 50-μL PCR mixture contained DNA 90-nt template (PBA, 5’-CCT TCG TTG TCT 
GCC TTC GTG AGC GGA GTC AGA CGC ACG CTC GTA CCT GTG CGC AAG CAC TAT 
GAC GGA CAC CCT TCA GAA TTC GCA CCA-3’, 10 nM), 20-nt primer 1 (5’-TGG TGC 
GAA TTC TGA AGG GT-3’, 1 μM), 20-nt primer 2 (5’-CCT TCG TTG TCT GCC TTC GT-3’, 
1 μM), dATP, dCTP, dGTP, dTTP or TCO-TTP at a concentration of 200 μM, 0.5 U μL-1 KOD-
XL DNA polymerase and 1× reaction buffer as provided by vender. Thirty thermal cycles were 
conducted with melting at 90 °C for 20 s, annealing at 48 °C for 20 s, and extending at 72 °C for 
30 s with initial denaturing at 90 °C for 2 min and final extension at 72 °C for 5 min. The PCR 
products were then analyzed by 15% PAGE. 
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Post-synthesis labeling of the PCR products was performed using similar procedures as 
those for primer extension. Specifically, TCO-DNA90 prepared from PCR was purified using 
Millipore Amicon 10 kDa spin column. Pre-purified TCO-DNA90 (20 μL) was then added to the 
2 μL of 10 mM Tz-BBA DMSO solution, which was further reacted at r.t. for 30 min. The 
negative control experiment was performed following the same procedure except using dNTPs-
DNA90, the PCR product using dNTPs and other reagents. The resulting DNA product after post-
synthesis modification was purified with Millipore Amicon 10 kDa spin column and analyzed by 
15% PAGE. 
1.3.6.5 Experimental Procedure of Fluorescence Labeling and Cell Imaging Studies: 
The PCR mixture of a final volume of 50 μL contained DNA 86-nt template (N37, 5’- 
ATA CCA GCT TAT TCA ATT CTG CCG GGA ACA CCG CGT GGC TCT CTG CAA CGC 
CCA GGA CAT ACC ACA TTA GAT AGT AAG TGC AAT CT-3’ 10 nM each), 18-nt primer 
1 or 5’-FAM 18-nt primer 1 (5’-(FAM)-ATA CCA GCT TAT TCA ATT-3’, 1 μM), primer 2 
(5’-AGA TTG CAC TTA CTA TCT-3’, 1 μM),155 dATP, dCTP, dGTP, dTTP or TCO-TTP at a 
concentration of 200 μM, 0.5 U μL-1 KOD-XL DNA polymerase and 1× reaction buffer as 
provided by vender. PCR thermal cycles were conducted as previous incorporation. Post-PCR 
labeling using Tz-FITC was performed with similar procedures as previous incorporation. The 
FITC-labeled DNA product was purified with Millipore Amicon 10 kDa spin column and 
analyzed by 15% PAGE. 
HeLa cells were seeded on rectangular coverslips in a 6-well plate until it achieved 90% 
coverage on surface before the imaging experiment and were grown in Dulbecco’s modified 
Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% PNS at 37 
°C with 5% CO2. The cells were then incubated with either FAM-N37 aptamer, or FITC-labelled 
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TCO37 aptamer at the same concentration in SELEX binding buffer161 for 30 min at 37 °C. After 
washing with phosphate buffered saline (PBS) for 2 times, the cells were fixed with ice-cold 
methanol for 5 min. Thereafter, the coverslips containing the cells were mounted onto the slides 
and imaged with a fluorescent microscope. 
1.3.7 Experimental procedure of cell-based SELEX using boronic acid-modified DNA 
molecules 
1.3.7.1 Initial DNA pool preparation 
The initial ssDNA library comprised of 80 bp, with a random 40 bp sequence in the 
middle flanked by 20 bp primers at 5’ and 3’ ends (5’-CCT TCG TTG TCT GCC TTC GTN 
NNN NNN NNN NNN NNN NNN NNN NNN NNN NNN NNN NNN NNN ACC CTT CAG 
AAT TCG CAC CA-3’). The initial DNA pool was dissolved in DI water to make 1 µM stock 
solution. The initial pool was first amplified with FAM-labeled primer (5’-FAM-CCT TCG TTG 
TCT GCC TTC GT-3’) and TCO-TTP to incorporate TCO-TTP into the sequences through PCR. 
Asymmetric PCR condition and amplification cycle program were as following: DNA library 
template (40 nM), FAM-labeled primer (4 µM), reverse primer (5’-TGG TGC GAA TTC TGA 
AGG GT-3’, 200 nM), dATP (396 µM), dCTP (396 µM), dGTP (396 µM), TCO-TTP (1.188 
mM), and KOD XL DNA polymerase (0.025 U/µL) in 500 µL. Thirty thermal cycles were 
conducted with melting at 90 °C for 20 s, annealing at 48 °C for 20 s, and extending at 72 °C for 
30 s with initial denaturing at 90 °C for 2 min and final extension at 72 °C for 5 min. TCO-
modified sequences prepared from PCR was purified using Millipore Amicon 10 kDa spin 
column. Pre-purified sequences solution (480 μL) was then added to the 24 μL of 10 mM Tz-
BBA DMSO solution, which was further reacted at r.t. for 1 h. The boronic modified products 
were then analyzed by 15% PAGE. This is the “0 round pool”. 
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1.3.7.2 Preparation of target cell and control cell 
The HPAF II cells (target cell) and MIA Paca cells (control cell) were cultured in 
DMEM/F-12 media and DMEM media, respectively, supplemented with 10% fetal bovine serum 
and 1% penicillin-streptomycin at 37 °C with 5% CO2. The cells were cultured in the 5.0 cm 
diameter cell culture dish until it achieved 90% coverage on surface before incubation. 
1.3.7.3 General selection procedure 
The target cell was incubated with the “0 round pool” (450 μL) in 10 mL SELEX binding 
buffer for 30 minutes at 37 °C. The cells were then washed 3 times with SELEX washing buffer 
and collected using a cell scraper. The collected cells were re-suspended in 250 µL DIH2O and 
heated for 10 minutes at 90 °C to release the sequences. The suspension was centrifuged at 1500 
rpm for 4 minutes. The supernatant collected was the template for the “1st round pool”. Next 
round sequence was synthesized using template selected from last round (100 µL), FAM-labeled 
primer and TCO-TTP through similar procedure stated above.  
1.3.7.4 Negative selection procedure 
After 3 rounds, a counter selection was introduced by incubating the sequence pool with 
the control cells (MIA Paca) for 30 minutes at 37 °C. Discard the bound sequences that are 
attached to control cells. The sequences that remained unbound to the control cells were further 
incubated with the target cells following the similar procedure as described above. Fluorescence 
imaging was used to monitor the binding of each round pool selected against the target cells.  
1.3.7.5 Monitoring the progress of selection 
The cells were cultured on coverslips in a 6-well plate until it achieved 90% coverage on 
surface before the imaging experiment. 100 µL of the selected pool was dissolved in 2 mL of 
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culture medium and incubated with the cells for 30 minutes at 37 °C. The cells were then washed 
2 times with PBS and fixed with 4% paraformaldehyde for 30 minutes at room temperature. The 
coverslips with the cell sample were mounted onto glass slides by using hard set mounting 
medium containing DAPI. The slides were imaged under FITC, or DAPI, or phase contrast 
channel by fluorescent microscope. 
1.3.7.6 Cloning and sequencing of enriched pools 
After binding was observed by fluorescent imaging, the sequences in the selected pool 
was cloned and sequenced for identification. The selected pool was prepared with the same 
procedure in pool amplification, except using non-labeled primer instead of FAM-labeled 
primer. 2 µL of the PCR product was added into the ligation-reaction mixture and incubated at 4 
°C for 30 minutes. The competent cells were thawed on ice and incubated for 5 minutes on ice 
after adding 2 µL of the ligation mixture. The competent cell tubes were then heat-shocked in 42 
°C water bath for 1 minute, followed by incubation on ice for 2 minutes. 500 µL of the SOC 
medium was added into the competent cell tube and 50 µL was spread onto one LB plate. The 
colonies were allowed to grow for 16 hours at 37 °C in an inverted plate position. The white 
colonies on the LB plate was picked and suspended into 5 mL of liquid LB medium and shaken 
vigorously for 12 hours. The E. Coli bacteria pallet was then collected by centrifuging at 10k 
rpm for 3 minutes. The plasmid of the bacteria was extracted using QIAprep® Miniprep kit and 
sent for sequencing in DNA core facility at Georgia State University. Meanwhile, the PCR 
product of the selected pool was also sent for next-generation sequencing (Core Facilities at the 
University of Florida). 
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1.3.7.7 Synthesis of potential single-stranded aptamer candidates 
The sequences of the highest abundance from the sequencing data were selected as the 
top aptamer candidates. The sequences were synthesized using phosphate-modified 
complementary template (5-phosphate C3UB2, 5'-phosphate-TGG TGC GAA TTC TGA AGG 
GTG CCG CCA CCT CCC CCG CCT TAT GCT CGG TCC ACC CGG CCC ACG AAG GCA 
GAC AAC GAA GG-3'), FAM-labeled sense primer 1 and TCO-TTP through similar PCR 
procedures. The product mixture was purified using Millipore Amicon 10 kDa spin column. The 
double strand was then incubated with lambda exonuclease for 4 hours at 37 °C to remove the 
phosphorylated strand. The remained single-stranded TCO-modified DNA (500 µL) was further 
reacted with 1mM BBA4 (25 µL) at r.t. for 1 hour. The boronic acid-modified product mixture 
then purified with spin column.  
1.3.7.8 Binding studies of aptamer candidates to cells  
The binding affinity was measured using fluorescence from FAM-labeled sequences by 
flow cytometry. 2 μM stock solution of selected sequences was prepared. Series diluted stock 
solution to 31.25 nM. HPAF II cells were dissociated with trypsin. Cells were washed with 
SELEX washing buffer and incubated with various concentration of sequences in 50 μL of 
binding buffer. After 30 minutes incubation, cells were washed and re-suspended with washing 
buffer, and further analyzed by flow cytometer. 
1.4 Conclusion 
A fast and efficient approach of post-PCR DNA modification is described. The modified 
TTP (TCO-TTP) has a click handle for reaction with tetrazine, which can be used for tethering 
other functional groups. Compared to previously reported methods, the approach described uses 
a very fast click reaction and has the advantage of significantly improved reaction kinetics. The 
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incorporation of a boronic acid functional group or a fluorophore has been described after the 
successful incorporation of TCO-TTP. The boronic acid-labeled DNA can be used for aptamer 
selection against carbohydrates and glycoproteins, while the fluorophore-labeled DNA can be 
used for cell labeling studies among other applications. Following labeling work, boronic acid-
modified aptamers that can selectively target HPAF II cell line was successfully selected and 
examined. Taking advantage of high binding affinity between boronic acid and glycoproteins, 
the selection efficiency is highly improved and selection rounds are decreased. This approach 
provides an efficient way to generated aptamer for glycoprotein on cell surface. In addition, the 
trans-alkene functional group in the modified DNA can also be used to tether other functional 
group for various purposes. 
1.5 Statements  
The much of the results described in this chapter has been published in Org. Biomol. 
Chem (Wang, K.; Wang, D.; Ji, K.; Chen, W.; Zheng, Y.; Dai, C.; Wang, B., Post-synthesis 
DNA modifications using a trans-cyclooctene click handle, Org. Biomol. Chem. 2015, 13 (3), 
909-915, DOI: 10.1039/C4OB02031F) and Curr. Org. Chem. (Wang, K.; Wang, D.; Wang, B., 
Modified nucleosides that can be incorporated into DNA enzymatically or in live cells, Curr. 
Org. Chem. 2015, 19 (11), 1011-1020, DOI: 10.2174/138527281911150610101141). In this 
chapter, my contributions include the synthesis of trans-cyclooctene-modified thymidine 
triphosphate (TCO-TTP), enzymatically incorporation of modified thymidine into DNA 
molecules through PCR, fluorophore and boronic acid functional groups labeling of DNA, 
aptamer-cell binding studies and partially on aptamer selection and cloning process.  
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2     DEVELOPMENT OF FLUORESCENT CHEMOPROBES FOR MOLECULES OF 
BIOLOGICAL IMPORTANCE  
2.1 Development of fluorescent chemoprobes for hydrogen sulfide (H2S) 
2.1.1 Introduction 
The past decade has seen a boost of research interest in hydrogen sulfide (H2S), which 
has been recently recognized as one of the three important gasotransmitter, including nitric oxide 
(NO)177 and carbon monoxide (CO).178 H2S is synthesized endogenously in the cell by enzymes 
such as cystathionine β-synthase (CBS)179 and cystathionine γ-lyase (CSE).180 And it is involved 
in the regulations of a series of important genes. Endogenous concentrations of H2S is related to 
a number of diseases such as Down syndrome181 and lung diseases.182 H2S was also found to 
show protective effects in the cardiovascular (CV)183 and central nervous systems (CNS)184 and 
to play a regulatory role in inflammation.185-186 Regulation of H2S levels is also a potential drug 
development strategy.187-188 The importance of accurate detection of H2S has been greatly 
emphasized. However, this is not a trivial issue mainly due to the low stability of this gaseous 
molecule. H2S is volatile and prone to oxidation. Considering the features of hydrogen sulfide, 
such as reducing ability and duo-nucleophilicity (can undergo nucleophilic addition or 
substitution twice), current detection for hydrogen sulfide uses either sulfide specific 
chemosensor (methylene blue method),189 electrochemical methods (sulfide selective electrodes 
or polarographic methods)190-191 and gas chromatography (GC).192 However, none of these 
methods is compatible with detection and imaging in cells. These methods also show problems 
such as narrow linearity ranges (methylene blue method) and complicated sample preparations 
(chromatography). Fluorescent probes are emerging as important tools for the selective and 
sensitive detection of H2S.193-195 Chang and our group first reported that the reduction of an azido 
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group attached to a fluorophore could be utilized for the design of H2S-selective fluorescent 
probes.196-197 Recently, a number of fluorescent probes have been developed, including probes 
based on nucleophilic cyclization,198-202 redox reactions,197, 203-206 and metal-sulfide formation.207-
209 A few reviews have been published discussing H2S probes.210-213 Some recently published 
probes are discussed below (Table 2.1). 
 
Table 2.1 Properties of hydrogen sulfide probes 
Probe 
Wavelength (λex/ 
λem, nm) or Abs. 
Reaction 
time (min) 
Tempera
ture (⁰C) pH Medium LOD 
Application in 
biological system 
Lyso-
NHS 450/ 555 20 37 7.4 ACN/ PBS 1: 9 0.48 uM serum and live  cells 
CouMC 475/ 510& 652 0.5 r.t. 7.4 2% DMSO-PBS 1 uM live cells 
probe 40 450/ 485& 690 0.17 r.t. 7.4 ACN/ PBS 1: 3.3 0.14 uM live cells 
HS-Cy 
510& 700/ 625& 
780 35 37 7.4 HEPES 5-10 nM live cells 
probe 46 
350/ 440, 510, & 
570 30 37 7.4 
DMSO: phosphate 
buffer 2: 8 10 uM live cells 
SFP-1 300/ 395 60 37 7.4 PBS 5-10 uM live cells 
SFP-2 465/ 510 240 37 7.0 PBS 6 uM live cells 
SFP-3 500/ 525 30 25 7.4 PBS 1.5 uM plasma 
SF4 496/517 60 25 7.4  HEPES 125 nM live cells 
SF5-AM 498/521 60  25 7.4 HEPES  250 nM live cells 
SF7-AM 498/526 60  25 7.4 HEPES 500 nM live cells 
SHS-M1 365/500 90 r.t.  7.4 HEPES  200 nM live cells, tissue 
SHS-M2 383/545 90 r.t.  7.4 HEPES 400 nM live cells, tissue 
MPhSe-
BOD 460/ 510 30 r.t. 7.4  PBS/ACN <10 µM live cells 
probe 68 440/544 180 r.t. 7.4 Phosphate buffer 500 nM live cells 
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2.1.1.1 Probes based on nucleophilic reactions 
In aqueous solution, H2S dissociates to form nucleophilic anion HS-, which can react with 
a variety of electrophiles. Taking advantage of this feature, a number of probes have been 
developed. One of the examples is reported by Cui and co-workers with specific subcellular 
localization property214 (Figure 2.1). This lysosome-targetable probe Lyso-NHS consists of a 
1,8-naphthalimide fluorophore, a 4-(2-aminoethyl)morpholine moiety (the lysosome targeting 
group), and a dinitrophenyl ether as the H2S reactive site. 
 
Figure 2.1 Structure of probe Lyso-NHS and its mechanism of action 
 
Among all fluorescent probes, ratiometric probes afford easy quantification due to the 
advantage of self-calibration. In 2013, Z. Guo and co-workers reported a ratiometric H2S probe 
CouMC (Figure 2.2), for detection in mitochondria.215 The selectivity for H2S over Cys, Hcy and 
GSH is achieved due to differences in pKa values. Biothiols have a higher pKa (> 8.5)216 than 
H2S (7.0), which makes H2S a better nucleophile in neutral medium. Another ratiometric 
fluorescent probe flavylium derivative (compound 40) was reported by W. Guo and co-workers 
recently (Figure 2.2).217 With a similar strategy, this probe featured a fast detection response (< 
10 s) and NIR property (λem: 485 and 690 nm) in ACN/PBS (1: 3.3). MTT cytotoxicity studies 
using HeLa cells showed 80% cell viability after incubation with 10 µM probe for 24 h.  
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Further increased sensitivity was achieved by a NIR probe HS-Cy reported by the Tang 
group (Figure 2.2)218 This probe takes advantage of the duo-nucleophilicity of hydrosulfide 
anion. It undergoes a nucleophilic addition by sulfide, followed by a thiolactone formation 
releasing a cyanine fluorophore. 
 
Figure 2.2 Structure of ratiometric H2S probes and their mechanisms of actions 
 
A white light-emitting fluorescent probe (46) reported by Lin and co-workers shows 
advantages of low-background multi-channel detection (Figure 2.3).219 This probe was 
constructed by conjugating a blue fluorescent dye and with an ESIPT (excited-state 
intramolecular proton transfer) dye, which is modified by a 2,4-dinitrophenyl group as the 
reactive site. This probe can be utilized to detect endogenous H2S in living cells with three-
channel monitoring. Although this probe is not as sensitive as some aforementioned probes, it 
features a new multi-channel sensor for hydrogen sulfide. 
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Figure 2.3 Structure of probe 46 and its mechanism of action 
 
A series of hydrogen sulfide probes (SFP1, 2, 3, Figure 2.4) were reported by the He 
group.220-221 Based on a Michael addition-cyclization mechanism, these probes (5-10 µM) 
selectively react with sulfide exhibiting more than 10-fold fluorescence increases. Furthermore, 
SFP-1 and SFP-2 can be applied in dynamic monitoring of enzymatic hydrogen sulfide 
biosynthesis. 
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Figure 2.4 Structures of SFP probes and its mechanism of action 
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2.1.1.2 Probes based on redox reactions 
In 2013, Chang and co-workers reported several bis-azido rhodamine analogues (SF4-
SF7, Figure 2.5) for cell imaging of hydrogen sulfide.222 Compared to the mono-azido probes 
reported in 2011, these bis-azido analogues exhibit improved sensitivity with detection limits 
ranging from 125-500 nM. Acetoxymethyl esters (SF5-AM, SF7-AM, etc.) were synthesized to 
provide cell-trappability for increased imaging sensitivity by maintaining a high dye 
concentration in the cells. Production of H2S was observed in HUVECs (human umbilical vein 
endothelial cells) using SF7-AM and it was found that H2S generation is dependent on NADPH 
oxidase (Nox) derived H2O2, providing evidence in support of H2S/H2O2 crosstalk.  
Ratiometric two-photon excitation fluorescent probes SHS-M1 and SHS-M2 (Figure 2.5) 
were reported recently by Kim and co-workers.223 The reduction of the 4-azidobenzyl group to 
the corresponding aniline triggers the cleavage of the carbamate, releasing the N-methylaniline 
analogues and resulting in a red shift from 420 to 500 nm for SHS-M1 and 464 to 545 nm for 
SHS-M2. This shift in emission provides feasibility for ratiometric detection of hydrogen sulfide 
for cellular imaging. The positively charged TPP serves as a mitochondria-targeting moiety. 
SHS-M2 was used to monitor H2S in cultured astrocytes and showed that H2S production 
decreased when CBS was knocked down by siRNA. It was also found that H2S level decreased 
in DJ-1-knockout astrocytes and brain slices as Parkinson’s disease models.  
A selenium-bearing fluorescent probe (MPhSe-BOD, Figure 2.5) was reported by Han 
and co-workers.224 It exhibits a reversible redox cycle between oxidation by hypochlorous acid 
(HClO) to MPhSeO-BOD (strongly fluorescent) and reduction by H2S back to the original probe 
(weakly fluorescent). In a confocal imaging experiment, this probe showed good cell 
permeability in murine macrophage cell RAW264.7. It also showed the ability to continuously 
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monitor the HClO/H2S redox cycles when the production of hypochlorous acid (HClO) in cells 
was stimulated by phorbol myristate acetate (PMA) or exogenous sulfide was added into the cell 
culture. Similar strategy was also used in a NIR fluorescent probe reported by the same group.225 
Another redox-sensitive naphthalimide-based fluorescent probe 68(Figure 2.5) was 
reported recently by Wang and co-workers.226 The reduction of hydroxylamine moiety by H2S 
led to the production of its amino analogue as well as a dramatic increase in fluorescence 
intensity. A detection limit of sub-micromolar concentration was achieved. Imaging experiments 
in astrocytes using this probe revealed good cell membrane permeability. However, the slow 
kinetics (reaction requires 180 min to finish) hampers imaging applications. A fluorescent 
protein (FP)-based hydrogen sulfide probe cpGFP-Tyr66pAzF was recently reported by the Ai 
group.227 
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Figure 2.5 Structure of redox-based H2S probes and their mechanism of action 
 
 
2.1.2 Results and discussion 
The redox-based fluorescent probe (DNS-Az), which was reported by our group, shows 
significant fluorescence “turn-on” effect in the presence of H2S in aqueous solutions. Most 
importantly, the sensing reaction (completes in minutes) is the fastest among all redox-based 
fluorescent probes for H2S. This might be attributed to the unique structure features of DNS-Az. 
Compared to other redox-based fluorescent probes bearing an azido group, DNS-Az includes a 
sulfonyl azide. We believe that the sulfonyl azide provides the probe with fast reaction rates and 
increased photo-stability. However, the quantum yield of the fluorescent species DNS-NH2 is 
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very low (< 0.05) in pure aqueous solutions. In order to reach higher sensitivity, a surfactant 
Tween-20 was added in previous experiments.196 Herein we describe the synthesis and 
evaluation of a new fluorescent probe, which shares structure similarity with the previously 
reported probe but emits a different wavelength with higher fluorescence quantum yield and 
detection sensitivity in phosphate buffer without addition of any surfactant.  
The structure of DNS-Az is based on a 1,5-dansyl fluorophore, which is known for its 
large Stokes shift (λex = 330 nm, λem = 517 nm in phosphate buffer/Tween-20). 2,6-Dansyl 
fluorophore has a smaller Stokes shift, however exhibits much higher fluorescence quantum 
yield in pure aqueous media.228 Therefore, it is conceivable that 2,6-dansyl azide (2,6-DNS-Az, 
73) might serve as a fluorescent probe for H2S with high detection sensitivity in pure aqueous 
media. Starting from commercially available 6-amino-2-naphthalenesulfonic acid (70), 2,6-
dansyl azide was synthesized in 3 simple steps, including reductive alkylation to form 
dimethylamino sulfonate 71, formation of sulfonyl chloride 72, and substitution with sodium 
azide to afford the sulfonyl azide 73 in 35% overall isolated yield. 
 
 
Scheme 2.1 Synthesis of 2,6-dansyl azide 
 
2,6-Dansyl azide was evaluated as a fluorescent probe for H2S. In all experiments, Na2S 
was used as the sulfide source in aqueous solutions as reported previously196 and elsewhere. As 
expected
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above their physiological levels, to test the selectivity of 2,6-DNS-Az. It was found that 2,6-
dansyl azide showed almost exclusive response to sulfide over other anions. For strong reducing 
anions such as HSO3-, S2O42-, and S2O52-, the selectivity was found to be 30 to 44-fold. Other 
reducing biological species, such as cysteine (Cys) and glutathione (GSH) at 100 μM, were also 
tested (Figure 2.10). The probe did not show fluorescence response to Cys and GSH. A slight 
increase in fluorescence response to sulfide was found in the presence of Cys and GSH. This 
could be due to antioxidative effect of Cys and GSH, which prevented undesired oxidation of 
sulfide in the reaction media. Selectivity over nucleophilic species was also tested by using high 
concentrations (1 mM) of glycine and lysine. These results have indicated that 2,6-DNS-Az 
shows sufficient selectivity for the detection of H2S in a complex biological sample. 
 
 
Figure 2.10 Fluorescence changes of 2,6-DNS-Az (20 μM) in the presence of (sulfide and) various 
anions. 
a. Fluorescence changes of 2,6-DNS-Az (1) in the presence of various anions; b. fluorescence 
changes of 2,6-DNS-Az (1, 20 μM) in the presence of sulfide and various anions (HS- 10 μM; 
HSO3-, S2O42-, and S2O52- 20 μM; all other anions 1 mM in 20 mM sodium phosphate buffer (pH 
7.4), λex= 325 nm). Anions tested: Cl-, Br-, I-, F-, OH-, OAc-, CN-, N3-, NO2-, NO3-, HCO3-, HSO3-
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, SO42-, S2O32-, S2O42-, S2O52-, and citrate. Data represents average of three independent 
experiments. 
 
 
Figure 2.11 Fluorescence response of 2,6-DNS-Az to sulfide in the presence and absence of reducing 
agents. 
Fluorescence response of 2,6-DNS-Az to sulfide in the presence and absence of reducing agents 
(cysteine 100 µM, GSH 100 µM) and nucleophilic amino acids (lysine 1 mM, glycine 1 mM) in 
0.1 M phosphate buffer (pH =7.4). 
 
For all quantitative analytical methods, a linear calibration curve is always preferred 
because it allows easy calculation. After confirming the selectivity of 2,6-DNS-Az, this probes 
was evaluated for quantitative measurement of H2S by testing concentration-dependent response 
of 2,6-DNS-Az  to sulfide. As shown in Figure 3, a linear correlation (R2 = 0.9993) was found 
for sulfide in phosphate buffer. As determined by 3:1 signal/noise ratio, the detection limit for 
sulfide in phosphate buffer is 1 μM (Figure 2.12). This indicates that 2,6-DNS-Az could be used 
for quantitative measurement of H2S in pure aqueous media. 
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Figure 2.12 Hydrogen sulfide concentration dependent fluorescence intensity changes. 
2,6-dansyl azide 20 μM, Na2S 0-10 μM in 100 mM phosphate buffer (pH 7.4, λex= 325 nm), Data 
represents average of three independent experiments. 
 
 
Figure 2.13 Measurement of LOD. 
Red line represents fluorescence response of 2,6-DNS-Az (20 µM) to sulfide (1.0 µM). Blue line 
represents the background fluorescence of 2,6-DNS-Az (20 µM) in 0.1 M phosphate buffer (pH 
=7.4). 
 
Due to the biological significance of H2S, the detection of H2S in biological systems such 
as blood serum is of great importance in both research and clinical applications. Therefore, we 
are also interested in using 2,6-DNS-Az for sulfide detection in serum. The probe was evaluated 
in fetal bovine serum (FBS). First, a reaction time profile was tested for 2,6-DNS-Az and sulfide. 
As shown in Figure 2.14, although FBS shows some background fluorescence, a very significant 
increase was still observed after addition of sulfide. Over 10-fold fluorescence increase was 
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observed for only 10 μM of sulfide. This indicates more than 2-fold higher sensitivity compared 
to 1,5-DNS-Az reported earlier by our group. The reaction of 2,6-DNS-Az with sulfide is very 
fast and completes in about 2 minutes in FBS. This is very promising considering that H2S is 
very unstable and easily consumed in biological systems. We also tested concentration-
dependent fluorescence changes of 2,6-DNS-Az in FBS. The linear calibration curve (R2 = 
0.995) obtained in FBS has also indicated that 2,6-DNS-Az could serve as a useful tool for H2S 
detection. The detection limit of H2S in FBS is about 6 μM. 
 
 
Figure 2.14 Reaction time and concentration dependent profile of 2,6-DNS-Az (20 μM) and H2S (10 
μM) in FBS 
a. Reaction time profile of 2,6-DNS-Az (20 μM) and H2S (10 μM) in FBS; b. H2S concentration 
dependent fluorescence intensity changes, determined using a fluorometer: 2,6-DNS-Az 20 μM, 
Na2S 0-10 μM in FBS (λex= 325 nm). Concentration dependence data represents average of three 
independent experiments. 
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2.1.3 Experimental Section 
2.1.3.1 General Information 
Solvents and reagents were purchased from VWR International, Oakwood Product Inc., 
or Sigma-Aldrich Co., and used without purification unless specified otherwise. When necessary, 
solid reagents were dried under high vacuum. Reactions with compounds sensitive to air or 
moisture were performed under argon. Solvent mixtures are indicated as volume/volume ratios. 
Thin layer chromatography (TLC) was run on Sorbtech W/UV254 plates (0.25 mm thick), and 
visualized under UV-light or by a Ce-Mo staining solution (phosphomolybdate, 25 g; 
Ce(SO4)2.4H2O, 10 g; conc. H2SO4, 60 mL; H2O, 940 mL) with heating. Flash chromatography 
was performed using Fluka silica gel 60 (mesh size: 0.040-0.063 mm) using a weight ratio of ca. 
30:1 for silica gel over crude compound. 1H and 13C-NMR spectra were recorded on a Bruker 
400 spectrometer (400 and 100 MHz, respectively) in deuterated chloroform (CDCl3), methanol-
d4 (CD3OD), or DMSO-d6 with either tetramethylsilane (TMS) (0.00 ppm) or the NMR solvent 
as the internal reference. UV-Vis absorption spectra were recorded on a Shimadzu PharmaSpec 
UV-1700 UV-Visible spectrophotometer. Fluorescence spectra were recorded on a Shimadzu 
RF-5310PC spectrofluorophotometer. 96-Well plates were read and recorded on a PerkinElmer 
1420 multilabel counter. 
2.1.3.2 Synthesis and Characterization 
6-(Dimethylamino)naphthalene-2-sulfonic acid 71: To a solution of compound 70 (220 
mg, 0.99 mmol) in acetonitrile (3 mL), formaldehyde (1 mL) was added dropwise. After the 
reaction mixture was stirred for 10 min, NaCNBH3 (450 mg, 7.2 mmol) was added in 2 portions. 
Then, AcOH (1 mL) was added in 4 portions during 4 h. The reaction was stirred at r.t. for an 
additional 2 h. The product precipitated out from the reaction solution. The white precipitate was 
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filtered out, washed with H2O and MeOH, and dried (225 mg, yield: 91%). 1H NMR (CD3OD): δ 
8.17 (1H, s), 7.79 (1H,d, J = 8.8 Hz), 7.75 (1H, d, J = 8.8 Hz), 7.69 (1H, d, J = 8.4 Hz), 7.28 
(1H, d, J = 8.8 Hz), 7.00 (1H, s), 3.08 (6H, s); MS (ES+) 252.1 (M+1)+. 
6-(Dimethylamino)naphthalene-2-sulfonyl azide 73: To an Ar-protected solution of 71 
(225 mg, 0.9 mmol) in POCl3 (1.1 mL) in an ice bath, PCl5 (832 mg, 4 mmol) was added in one 
portion. The reaction mixture was stirred at 0 oC for 2 h. Then, the reaction was stirred at r.t. for 
an additional 2 h. The reaction mixture was poured into 100 g ice and the product was extracted 
with EtOAc (100 mL × 3). The organic phase was dried over Na2SO4, and concentrated under 
vacuum to yield crude product 72. The crude product 72 was dissolved in THF (5 mL) and added 
into a stirred solution of NaN3 (580 mg, 9 mmol) in a 1:1 mixture of THF/H2O (10 mL). The 
reaction mixture was stirred at room temperature for 2 h. Organic solvent was evaporated to 
obtain light yellow solid. The crude product was purified by flash chromatography purification 
(Hex: EtOAc, 20: 1) to give compound 73 as light yellow solid (134 mg, 54%). 1H NMR 
(CDCl3): 8.33 (1H, s), 7.82 (1H, d, J = 9.2 Hz), 7.72 (2H, s), 7.24 (1H, t, J = 9.2 Hz), 6.88 (1H, 
s), 3.14 (6H, s); 13C NMR (CDCl3): 151.0, 138.0, 130.7, 129.6, 127.5, 124.2, 122.5, 117.2, 
104.9, 40.3; IR 2133, 1614 1507, 1361, 1069, 840, 812, 739; MS (ES+) 277.1 (M+1)+. 
6-(Dimethylamino)naphthalene-2-sulfonamide 74: To a stirred solution of 2,6-DNS-Az 
(19.8 mg, 0.072 mmol) in 1.44 mL acetonitrile was added dropwise a solution of Na2S (51.6 mg, 
0.22 mmol) in H2O. The solution was stirred at r.t. for 30 min and was dried under vacuum. The 
crude product was purified by column chromatography to give compound 74 as white solids (13 
mg, 72%). 1H NMR (DMSO-d6, 400 MHz): 8.18 (1H, s), 7.90 (1H, d, J = 9.2 Hz), 7.78 (1H, d, J 
= 8.8 Hz), 7.68 (1H, d, J = 8.8 Hz), 7.31 (1H, d, J = 9.2 Hz),7.24 (2H, s), 6.99 (1H, s), 2.50 (6H, 
s); MS (ES+) 251.08 (M+1)+. 
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2.1.3.3 Relative quantum yield determination of 2,6-DNS-Az and 2,6-DNS-NH2  
1,5-DNS-NH2 was used as the reference for relative quantum yield determination. 
Absorption and emission (λEx= 325 nm) spectra were recorded for a series of concentrations (16 
µM, 12 µM, 8 µM, 4 µM and 0 µM in deionized water) of 1,5-DNS-NH2, 2,6-DNS-NH2, and 
2,6-DNS-Az. Integrated fluorescence intensity was plotted against the absorption values at each 
concentration (Figures 2.15 and 2.16).229 Relative quantum yield values can be calculated using 
slopes of each compound. 
 
Figure 2.15 Quantum yield determination of 2,6-DNS-Az (0-20 µM) in H2O 
 
 
Figure 2.16 Quantum yield determination of 1,5-DNS-NH2 (0-20 µM) in H2O 
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2.1.4 Conclusions 
The biological significance as well as difficulty in accurate detection of H2S urged 
chemists to find new detection methods. We have reported previously a fluorescent probe (1,5-
DNS-Az) for H2S detection, but requires the addition of Tween-20 to achieve sufficient 
sensitivity when used in buffer solutions. The present work reports the development and 
evaluation of a new fluorescent probe for H2S, 2,6-DNS-Az. This probe shows much higher 
fluorescence change in pure aqueous media (>100-fold for 10 µM of sulfide) compared to the 
probe described earlier (8-fold) without addition of any surfactant. High detection sensitivity, 
almost exclusive selectivity and excellent linear correlation for sulfide in aqueous solution and 
blood serum make this probe a useful tool for quantitative detection of H2S. 
2.1.5 Statements 
The much of the results in this chapter has been published in J. Fluoresc. (Wang, K.*; 
Peng, H.*; Ni, N.; Dai, C.; Wang, B., 2,6-Dansyl azide as a fluorescent probe for hydrogen 
sulfide. J. Fluoresc. 2014, 24 (1), 1-5, DOI: 10.1007/s10895-013-1296-5) and J. Cell. Biochem. 
(Wang, K.; Peng, H.; Wang, B., Recent advances in thiol and sulfide reactive probes. J. Cell. 
Biochem. 2014, 115 (6), 1007-1022, DOI: 10.1002/jcb.24762). In this chapter, my contributions 
include fluorescence studies and quantitative determination of hydrogen sulfide probe. 
2.2 Development of fluorescent chemoprobes for homocysteine (Hcy) 
2.2.1 Introduction 
Thiols, such as cysteine (Cys), homocysteine (Hcy) and glutathione (GSH) (Figure 2.17), 
are indispensable functional molecules in the biological system due to the strong nucleophilicity 
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and redox reactivity of the sulfhydryl group.230 Thiols are ideal nucleophiles in enzyme 
functions, excellent sensors231 and mild buffering molecules for maintaining cellular redox 
states.232-233 Biological thiols play versatile roles in various processes, including protein structure 
and functions, antioxidant activity, and redox signaling. Hcy is a key intermediate generated 
during the biosynthesis of Cys.234-235 Plasma Hcy exists in three major forms including free 
reduced (~1%), free oxidized (30%) and protein-bound oxidized (70%) forms.236-237 Fluctuations 
in thiol concentrations can indicate or even lead to a variety of cardiovascular disorders and 
neurodegenerative diseases. For example, circulating Hcy has been correlated with Alzheimer’s 
disease238 and coronary artery diseases,239-240 Excessive amount of total Hcy (tHcy) in the 
blood,241  hyperhomocysteinemia (HHcy), is related to folate deficiency, which can lead to 
miscarriage242 and various tumors.243 According to the American Heart Association (AHA) 
advisory statement, normal tHcy concentrations range from 5-15 µM; moderate, intermediate, 
and severe hyperhomocysteinemia refer to concentrations between 16 and 30, between 31 and 
100, and >100 µM, respectively, and are essentially pathognomonic.244 Cys deficiency is 
associated with slow growth, and liver and skin damage.245 High Cys concentration exhibits 
neurotoxicity.246 Decrease in GSH concentration was also shown to be associated to Parkinson’s 
disease.247 As a result, accurate determination of these biological thiols, especially of Hcy in 
biological systems such as blood plasma and urine are of great importance in both clinical and 
research practice. 
 
Figure 2.17 Structures of Cysteine (Cys), Homocysteine (Hcy) and Glutathione (GSH) 
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By taking advantage of the unique chemical properties of the sulfhydryl group, such as 
strong nucleophilicity and low redox potential (-0.2~-0.3 V),248-249 general detection of thiols can 
be achieved using thiol reactive probes and electrochemical probes.250 For determination of 
specific thiols, both detection methods can be coupled with different separation technology, such 
as chromatography and capillary electrophoresis (CE). Chemically derivatized thiols can also be 
selectively detected using mass spectrometry (MS). Due to the low redox potential of the 
sulfhydryl group, thiols (R-SH) are readily oxidized to their disulfide state. For example, more 
than 95% of total Hcy is in the oxidized form,251 while only a very small amount is in the form of 
free thiol. Therefore, a reducing pre-treatment is usually required to convert all thiol species to 
their reduced forms before analysis of total thiol concentrations. Reducing agents such as 
dithiothreitol (DTT), tris(2-carboxyethyl)phosphine (TCEP),252 or sodium borohydride (NaBH4) 
can be used for the reduction of disulfide bonds. Because the chemical derivatization relies on 
the nucleophilicity of the sulfhydryl group (pKa of –SH in cysteine:253 8.15, Hcy: 8.7, GSH: 
8.56), pH of the media is also an important factor affecting the reaction rates and outcomes. 
Basic buffer condition is often used to deprotonate sulfhydryl group and to accelerate the sensing 
reaction.254-255 For thiol reactive probes, numerous reaction types have been utilized, including 
nucleophilic substitution, Michael addition, cyclization, and cleavage of disulfide bond, metal 
complexes coordination, and redox reactions.  
Normal tHcy is lower than 15 µM in plasma, which is about 1/20 of the total Cys 
concentration.251 Due to high degree of similarity in both structure and chemical properties 
between Hcy and other thiols such as Cys, the selective detection of Hcy has never been a trivial 
issue. Current detection methods for Hcy involve the derivatization at the sulfhydryl group using 
electrophilic fluorogenic reagents.256-258 However, due to the lack of selectivity among different 
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biological thiols, these methods require tedious separating techniques such as GC and HPLC. 
This has led to an increased cost and reduced efficiency and thus limited the applicability of Hcy 
as an important biomarker. Therefore, selective recognition of Hcy over other biological thiols is 
of great interest. In this and the following sections, Cys/Hcy-specific probes, and Hcy -specific 
probes (Table 2.2) are discussed. 
 
Table 2.2 Properties of Cys and Hcy probes 
Probe Analyte Wavelength (λex/ 
λem, nm) or Abs. 
Reaction 
time (min) 
Tempera
ture (oC) 
pH Medium LOD Application in 
biological system 
CIC Cys/ Hcy 430/547 30 37 7.2 DMSO: 
HEPES 9: 1 
N.D.  N.D.  
MV2+ Hcy 510 (Abs.) 5 r.t. 7.5 Tris N.D.  plasma 
fluorone 
black 
Hcy 510 (Abs.) 5 r.t. 7.3 phosphate 
buffer 
N.D.  plasma 
FSN-
AuNPs 
Hcy 370/ 485 120 r.t. 13 phosphate 
buffer 
4.4 nM plasma 
Tris: tris(hydroxymethyl)aminomethane 
 
In 2010, Li reported an inorganic phosphorescent imaging probe, cationic iridium (III) 
complex (CIC) (Figure 2.18), for Cys and Hcy detection in living cells.259 Upon addition of 
aminothiols, the probe’s luminescence changes from yellow to red in DMSO-HEPES (9: 1). This 
makes it a “naked-eye” indicator of Cys or Hcy. With its membrane-permeable property, CIC 
can ratiometrically indicate the intracellular Cys and Hcy concentrations. 
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Figure 2.18 Structures of Cys/Hcy-specific probes and their mechanisms 
 
 
Two Hcy-specific probes based on redox chemistry were reported by the Strongin 
group.255, 260 One visual detection probe was methyl viologen (MV2+) (Figure 2.19), which 
responded to Hcy changing from colorless to blue in 5 min. Another commercially available 
probe fluorone black (Figure 2.19) shared a similar mechanism as that of MV2+ with higher 
detection sensitivity (linearity working range 0-15 µM).  
 
Figure 2.19 Structures of Hcy-specific probes and their mechanisms of action 
 
Another quantitative detection method of Hcy in plasma was reported by Tseng and co-
workers in 2012.254 The combination of TCEP reduction, fluorosurfactant-capped gold 
nanoparticles (FSN-AuNP) extraction and subsequent o-phthaldialdehyde (OPA) derivatization 
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(Figure 2.20) provided a selective and sensitive method for quantification of total Hcy as well as 
protein-bound, free, and free oxidized Hcy. To avoid the interference of Cys, particle size of 
FSN-AuNPs was increased from 12 nm to 40 nm, which led to a higher aggregation rate of Hcy-
attached AuNPs than Cys-attached.261 In addition, OPA can selectively react with Hcy forming a 
highly fluorescent (9-fold intensity increase) product emitting at 485 nm with excitation at 370 
nm.262 Within the dynamic range 0.01-1 µM, the detection limit of this method was determined 
to be 4.4 nM. This detection method can provide more than 100-fold selectivity toward Hcy over 
other aminothiols in plasma. However, the detection pH of this probe was 13, which cannot be 
widely used in detection in a biological system. 
 
Figure 2.20 Schematic presentation of probe FSN-AuNPs assay and its mechanism of action 
 
Fluorescent probes based on cyclization mechanisms using both the amino and sulfhydryl 
groups have been reported mostly selective for Cys.263-267 The Strongin group found a 
colorimetric method for selective Hcy detection based on a radical mechanism.268-271 They also 
reported a fluorescent probe showing different reaction profiles for Hcy and Cys and thus their 
simultaneous detection.264 The Yoon lab recently reported a pyrene-based fluorescent probe 
functionalized with an aldehyde moiety selective for Hcy.272 Herein we report a redox-sensitive 
fluorometric detection of Hcy using a dansyl azide analogue 1 (DN-2).  
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2.2.2 Results and discussion 
During our search for redox-sensitive fluorescent probes for H2S,273 we discovered a 
dansyl-based fluorescent probe (DN-2) with selectivity towards Hcy over other biological thiols 
such as Cys and GSH in aqueous media. It is well known that thiols show reducing ability and 
help to maintain the redox states in biological systems. Redox reactions have been employed in 
thiol detections. For example, Ellman’s reagent (5,5’-dithiobis-2-nitrobenzoic acid or DTNB)274 
is widely used in the quantitation of sulfhydryl groups through the reductive cleavage of a 
disulfide bond, which releases the chromogenic indicator. However, only a few studies have 
been reported on the difference in reducing ability among thiols.275-276 
Specifically, we have synthesized dansyl derivative 87 (DN-2) as a fluorescent probe. 
The synthesis of DN-2 is accomplished in 3 steps from commercially available starting materials 
(Scheme 2.2). The substitution reaction between 5-naphthol-1-sulfonate 84 and ethylene diamine 
was followed by reductive amination, which installed three methyl groups on the amino 
groups.277 Then the sulfonate was converted to sulfonyl chloride, which reacted quantitatively 
with sodium azide to form the sulfonyl azide, DN-2 (87). This short and convenient synthetic 
route has provided the probe in a 37% isolated yield.  
 
Scheme 2.2 Synthesis of the fluorescent probe DN-2 
 
Fluorescence spectroscopy was used to monitor the reaction between DN-2 and 
biological thiols, Cys, Hcy, and GSH. As is shown in Figure 1, a significant fluorescence 
increase (~25-fold) at around 517 nm was observed for Hcy. Such fluorescent changes are also 
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readily visible to the naked eyes (Figure2.21, insert). However, with Cys and GSH, only 2 and 3-
fold fluorescence intensity change was observed, respectively. Spectroscopic (1H NMR, 13C 
NMR, and MS) identification of the product confirmed that the sulfonyl azide was reduced by 
Hcy, forming the corresponding sulfonamide and homocystine (Scheme 2.3). The fluorescence 
increase was due to the formation of highly fluorescent DA-2 (ΦFL (DN-2) = 0.007 and ΦFL (DA-
2) = 0.58 in acetonitrile, ΦFL (DN-2) = 0.02 and ΦFL (DA-2) = 0.29 in water, Figure 2.22). 
 
Scheme 2.3 Sensing reaction of DN-2 with Hcy 
 
 
Figure 2.21 Fluorescence spectrum of DN-2 in the presence of different amino thiols. 
Fluorescence spectrum of DN-2 in the absence and presence of different amino thiols; insert: 
time dependent fluorescence emission (517 nm) of DN-2 in the presence of different Hcy and 
Cys, and comparison of fluorescence intensity change with the addition of different amino thiols. 
(DN-2 120 µM, amino thiols 100 µM in 100 mM sodium phosphate buffer at pH 7.4 with 10% 
ethanol, fluorescence spectrum and pictures were recorded 1 h after the addition of thiols). 
0
100
200
300
400
500
600
700
800
360 410 460 510 560 610
Fl
uo
re
sc
en
ce
 In
te
ns
ity
Wavelength (nm)
DN2
Hcy
Cys
GSH
0
200
400
600
800
0 20 40 60 80 100
Time (min)
Hcy
Cys
GSH
DN2
75 
 
 
Figure 2.22 Quantum yield determination of DN-2 and DA-2. 
a. Quantum yield determination of DN-2 and DA-2 in acetonitrile; b. quantum yield 
determination of DN-2 and DA-2 in water. 1,5-DNS-NH2 was used as the reference for relative 
quantum yield determination. Absorption and emission (λEx= 325 nm) spectra were recorded for 
a series of concentrations (16 µM, 12 µM, 8 µM, 4 µM and 0 µM in acetonitrile or deionized 
water) of 1,5-DNS-NH2, DN-2 (1) and DA-2 (2). Integrated fluorescence intensity was plotted 
against the absorption values at each concentration.229 Relative quantum yield values can be 
calculated using slopes of each compound 
 
Next we compared the reaction time profile of DN-2 to thiols. Specifically, DN-2 was 
dissolved in the solution to a final concentration of 120 µM, while thiol concentrations were 100 
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µM. The probe, DN-2 was only weakly fluorescent in solvent systems, including acetonitrile 
(ACN), 100 mM sodium phosphate buffer at pH 7.4, and water. Immediately after the addition of 
thiols, an initial small increase in fluorescence was observed for all species (Figure 2.21, left 
inset). However, the fluorescent intensity quickly reached a plateau for Cys and GSH. For Hcy, 
the fluorescence intensity reached a plateau at about 1 h point at a much higher level. The 
selectivity for Hcy over Cys and GSH was found to be 8-12-fold. However, since GSH 
concentration in plasma is as low as ~2 µM,278 one would not expect interference problem with 
GSH. 
To further test the feasibility of DN-2 as a fluorescent probe in a complex biological 
system, the selectivity of DN-2 was tested among various amino acids in phosphate buffer with 
10% ethanol (Figure 2.23). It was found that DN-2 did not respond to most amino acids. A 
selectivity of over 45-fold was found among these amino acids at 100 µM. The reaction between 
DN-2 and Hcy was carried out in the presence of various amino acids (100 µM) (Figure 2.23b) 
in order to test how the presence of other amino acids affects the fluorescence response of DN-2 
to Hcy. It was found that the fluorescence response of DN-2 to Hcy was elevated by ~40% in the 
presence of 100 µM Cys. GSH showed similar effect. In contrast, none of the other amino acids 
affected the detection of Hcy. In addition, other possible reducing species in biological samples, 
such as Fe(II), Cu(I), and ascorbate, showed no reactivity with DN-2 (Figure 2.24) 
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Figure 2.23 Fluorescence response of DN-2 to amino acids. 
a. Fluorescence response of DN-2 to amino acids; b. fluorescence response of DN-2 to Hcy in 
the presence of amino acids. (DN-2 120 µM, amino acids 100 µM in 100 mM sodium phosphate 
buffer at pH 7.4 with 10% ethanol, fluorescence intensities were recorded 1 h after the addition 
of amino acids. Data represents the average of three independent experiments.) 
 
Figure 2.24 Fluorescence response of DN-2 to metal ions 
Fluorescence response of DN-2 to FeCl2, FeSO4, CuBr, CuCl, CuI, and ascorbic acid in 
comparison with negative control (DN-2 alone) and positive control (Hcy addition to DN-2 
solution). (DN-2 120 µM, analytes 100 µM in 100 mM sodium phosphate buffer at pH 7.4 with 
10% ethanol, fluorescence intensities were recorded 1 h after the addition of reducing species. 
Data represents the average of three independent experiments.) 
 
A fluorescent probe is especially useful for quantitation if a linear calibration curve could 
be obtained. Therefore, experiments were performed to obtain a calibration curve using a series 
of concentrations for Hcy. As expected, a linear calibration curve with R2 >0.99 was obtained for 
Hcy (Figure 2.25). This linearity is very important for quantitative analysis of Hcy. 
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Figure 2.25 Calibration curve for Hcy. 
DN-2 120 µM, Hcy 100 µM in 100 mM sodium phosphate buffer at pH 7.4, with 10% ethanol; 
fluorescence intensities at 517 nm were recorded 60 min after the addition of Hcy. Data 
represents the average of three independent experiments. 
 
Since the presence of Cys was found to increase the fluorescence response of DN-2 to 
Hcy by ~40%, we were interested whether endogenous Cys fluctuations (~200-250 µM) would 
affect Hcy detection. In order to test the effect of Cys fluctuation, calibration curves of Hcy at 0-
50 µM was generated in the presence of 200 and 250 µM of Cys (Figure 2.26). It was found that 
these two curves are very close, though not identical. Therefore, the accuracy of Hcy quantitation 
may be affected by Cys fluctuation. However, the selectivity of DN-2 to Hcy still allows a good 
estimation of Hcy level with large (~50 µM) fluctuation of Cys concentrations.  
 
Figure 2.26 Calibration curve of homocysteine in the presence of 200 and 250 µM of cysteine. 
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DN-2 120 µM, Hcy 0-50 µM in 100 mM sodium phosphate buffer at pH 7.4, with 10% ethanol; 
fluorescence intensities at 517 nm were recorded 60 min after the addition of Hcy. Data 
represents the average of three independent experiments. 
 
As arylsulfonyl azide was found to be a very sensitive fluorescent probe for sulfide,258, 279 
DN-2 also reacts with sulfide. In order to exclude the influence of sulfide in the selective 
detection of Hcy, a solution of ZnCl2 could be added into the reaction buffer to precipitate 
sulfide out of the solution in the form of ZnS (Ksp(ZnS)~2×10-25). It was found that the presence 
of high concentration of Zn2+ (at 300 µM) shows very little interference with the fluorescence 
response of DN-2 to Hcy (Figure 2.27).  
 
Figure 2.27 Fluorescence response of DN-2 to Hcy in the presence of different concentrations of 
Zn2+ 
DN-2 120 µM, Hcy 100 µM in 100 mM phosphate buffer with 10% ethanol at pH 7.4. 
Fluorescence was recorded on a fluorometer after reaction for 120 min in the presence of 0, 50, 
100, 200 and 300 µM of ZnCl2, respectively. Data represents the average of three independent 
experiments. 
 
Due to the significance of Hcy in biological system, the application of this probe in serum 
was examined. In diluted (10%) deproteinized fetal bovine serum (FBS), with addition of Hcy, 
this probe selectively responded to Hcy over Cys (Figure 2.28, insert). Furthermore, 
concentration-dependent fluorescence changes of DN-2 in diluted deproteinized FBS were 
observed. A linear calibration curve (R2 = 0.9997) was obtained suggesting the potential utility 
0
100
200
300
400
500
600
700
0 50 100 150 200 250 300 350
Fl
uo
re
sc
en
ce
 In
te
ns
ity
Zn2+ conc.
80 
of DN-2 in serum. The detection limit of Hcy in deproteinized FBS was 10 µM based on a 3-fold 
signal-to-noise ratio. 
 
Figure 2.28 Calibration curve for Hcy 
DN-2, 120 µM, Hcy, 0-100 µM in diluted deproteinized FBS, fluorescence intensities at 517 nm 
were recorded 180 min after addition of Hcy. Data represents the average of three independent 
experiments; Insert shows time-dependent fluorescence response of DN-2 (120 µM) to Hcy (100 
µM) or Cys (100 µM) in diluted deproteinized FBS. 
 
Our experiments have found that DN-2 selectively oxidizes Hcy in buffer and diluted 
deproteinized FBS. Although Cys is reduced by DN-2 at very high concentrations (~100 mM), 
there is apparently a large difference at lower concentrations. Thus, we were interested in 
achieving an understanding of the difference in reducing ability between Cys and Hcy. Hcy has 
one extra methylene group compared to Cys. However, this does not make its sulfhydryl group a 
stronger nucleophile since most nucleophilic substitution-based fluorescent probes show similar 
reactivity with both thiols. We have also examined the pKa of the sulfhydryl groups on Cys and 
Hcy using pH titration.280 It was found that the pKa was 8.25 for Cys and 8.9 for Hcy (Figure 
2.29), similar to most previously reported values.280-281 (In another paper, the pKa of –SH group 
was reported to be as high as 10.282) According to these pKa values, Cys should be deprotonated 
more easily than Hcy. Therefore, one would expect that Cys being a stronger reducing agent than 
Hcy if pKa was the determining factor. Fluorescent/colorimetric probes with disulfide moieties 
show comparative or slightly higher reactivity to Cys.283-284 This may be due to their difference 
y = 3.7641x + 18.252
R² = 0.9997
0
50
100
150
200
250
300
350
400
450
0 20 40 60 80 100
Fl
uo
re
sc
en
ce
 In
te
ns
ity
 a
t 5
17
 n
m
Conc. (uM)
0
100
200
300
400
0 50 100 150 200
FL
 51
7 n
m
Time (min)
Hcy
Cys
81 
in pKa. However, this is not the case in the redox reaction between these thiols and DN-2, where 
a different mechanism is indicated. In fact, it has been reported that oxidation of Hcy by albumin 
is faster than that of Cys and the oxidation is accelerated by basic conditions or addition of a 
copper catalyst.276, 285  
 
 
Figure 2.29 Titration curves of cysteine and homocysteine. 
a. Titration curve of 5 mM cysteine hydrochloride; b. Calculation of the sulfhydryl group pKa of 
cysteine; c. Titration curve of 5 mM homocysteine hydrochloride; d. Calculation of the 
sulfhydryl group pKa of homocysteine. NaOH solution (99.35 mM) was standardized with 
potassium hydrogen phthalate (KHP) and used for titration of 5 mM cysteine hydrochloride and 
5 mM homocysteine hydrochloride. Experiment was triplicated to obtain the average pKa values 
(8.25 for cysteine and 8.9 for homocysteine). 
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The reduction mechanism of an azido compound by a dithiol has been proposed in a 
previous report.286 Based on the experimental results, we propose that the initial attack by thiol 
leads to the formation of an intermediate 90 (Scheme 2.4), which is responsible for the initial 2-
3-fold fluorescence increase. Proton transfer then occurs to neutralize the negatively charged 
nitrogen leading to intermediates 89b and 89c. In the case of Hcy, the amino group then attacks 
the sulfur to form a five-membered ring intermediate 7, which then reacts with another molecule 
of thiol to form the disulfide product. The intermediate 90 then releases N2 to provide the 
sulfonamide product 88. In the case of Cys, a similar intramolecular attack would lead to a 
strained four membered ring 92, which would be unstable and thus unfavorable. In addition, the 
reversibility of the initial step means that the intermediate (89) exists in equilibrium with the 
starting materials and thus the probe (87) is available to react with Hcy even in the presence of 
Cys. In fact, cyclic transition states/intermediates have been used to explain the mechanisms of 
other Cys- or Hcy-selective probes.264, 268-269 It is entirely possible that there are other 
conformational factors, which affect the reactivity of intermediate 89. In the last step, another 
thiol comes to attack the sulfur to form a disulfide. Although gaseous diatomic bond energy for 
general S-N bond is higher than S-S bond,287 the formation of disulfide bond from the attack of 
sulfhydryl group on an electron-deficient S-N bond has been reported previously.288 In this step, 
it is conceivable that when excessive amount of Cys exists in the reaction media, a Cys-Hcy 
mixed disulfide could also form. This explains why Cys alone does not trigger fluorescence 
increase but causes a ~40% increase in fluorescence response to Hcy. It should be noted that a 
previously published dansyl azide analogue, 1,5-DNS-Az also shows selectivity for Hcy (Figure 
2.30). 
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Scheme 2.4 Proposed mechanism 
 
 
Figure 2.30 Time dependent fluorescence emission (517 nm) of 1,5-DNS-Az in the presence of Hcy 
and Cys 
DNS-Az 120 µM, amino thiols 100 µM in 100 mM sodium phosphate buffer at pH 7.4 with 10% 
ethanol 
 
In addition, the influence of pH on the selectivity has also been tested using 96-well plate 
and a microplate reader (Figure 2.31). Sodium phosphate buffer (100 mM) in the pH range of 
5.3-11.5 was used in the experiments. A pH dependent fluorescence response was observed for 
DN-2 in the presence of thiols. It was found that DN-2 itself remains fluorescently stable at pH 
0
100
200
300
400
500
600
700
800
0 20 40 60 80
Fl
uo
re
sc
en
ce
 In
te
ns
ity
 a
t 5
17
 n
m
 
Time (min)
Hcy Cys
84 
values lower than 10.5. The selectivity for Hcy increased with increasing pH from 5-7.4. In 
buffers at pH higher than 7.4, reactions with Cys and GSH were promoted. Therefore, the 
highest selectivity was observed at pH 7.4, which is the physiological pH. We have also 
examined the reaction time profile in phosphate buffer at 37 °C (Figure 2.32). The result has 
suggested that heat facilitated the reaction. The reaction time for 120 µM of DN-2 and 100 µM 
of Hcy decreased from 60 min at room temperature (about 22 °C) to 30 min at 37 °C. 
 
Figure 2.31 pH dependent fluorescence response of DN-2 to thiols. 
Fluorescence intensity was read on a microplate reader (Excitation filter 340 nm, Emission filter 
535 nm). DN-2 100 µM, thiols 100 µM in 100 mM sodium phosphate buffer at pH values of 5.3, 
6.2, 7.0, 7.5, 8.3, 9.0, 10.5, and 11.5. 
 
 
Figure 2.32 Reaction time profile at 37 °C. 
DN-2 120 µM, amino thiols 100 µM in 100 mM sodium phosphate buffer at pH 7.5, 37 °C, 
fluorescence intensities at 517 nm were recorded at each time point 
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2.2.3 Experimental section 
2.2.3.1 General Information 
Solvents and reagents were purchased from VWR International, Oakwood Product Inc., 
or Sigma-Aldrich Co. and used without purification unless specified otherwise. When necessary, 
solid reagents were dried under high vacuum. Reactions with compounds sensitive to air or 
moisture were performed under argon. Solvent mixtures are indicated as volume/volume ratios. 
Thin layer chromatography (TLC) was run on Sorbtech W/UV254 plates (0.25 mm thick), and 
visualized under UV-light or by a Ce-Mo staining solution (phosphomolybdate, 25 g; 
Ce(SO4)2.4H2O, 10 g; conc. H2SO4, 60 mL; H2O, 940 mL) with heating. Flash chromatography 
was performed using Fluka silica gel 60 (mesh size: 0.040-0.063 mm) using a weight ratio of ca. 
30:1 for silica gel over crude compound. 1H and 13C NMR spectra were recorded on a Bruker 
400 spectrometer (400 and 100MHz, respectively) in deuterated chloroform (CDCl3), methanol-
d4 (CD3OD), and DMSO-d6 with either tetramethylsilane (TMS) (0.00 ppm) or the NMR solvent 
as the internal reference. UV-Vis absorption spectra were recorded on a Shimadzu PharmaSpec 
UV-1700 UV-Visible spectrophotometer. Fluorescence spectra were recorded on a Shimadzu 
RF-5310PC spectrofluorophotometer. 96-Well plates were read and recorded on a PerkinElmer 
1420 multi-label counter. Automatic pH titration on a Accumet@ Research, AR10 pH meter was 
used to determine the pKa values of the sulfhydryl groups on cysteine and homocysteine. 
Titration curve was created and analyzed using TitriSoft 2.51. 
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2.2.3.2 Synthesis and Characterization 
5-(2-Aminoethylamino)naphthalene-1-sulfonic acid 84 and 5-(N-(2-(dimethylamino) 
ethyl)-N-methylamino)naphthalene-1-sulfonic acid 85 was performed following literature 
reported procedures.277 
5-(N-(2-(Dimethylamino)ethyl)-N-methylamino)naphthalene-1-sulfonyl azide 87: To a 
Ar protected solution of 85 (110 mg, 0.36 mmol) in POCl3 (570 µL, 6.2 mmol) was added PCl5 
in 2 portions (430 mg, 2.1 mmol). The reaction was stirred on ice bath for 1 h, then warmed to 
room temperature, and stirred for additional 2 h. The reaction mixture was poured into 10 g ice. 
EtOAc extraction and evaporation gave crude intermediate 5-(N-(2-(dimethylamino)ethyl)-N-
methylamino)naphthalene-1-sulfonyl chloride, which was dissolved in MeOH (2 mL) and added 
into a stirred solution of NaN3 (243 mg, 3.75 mmol) in a 1:1 mixed solvent of MeOH/H2O (4 
mL). The reaction mixture was stirred at room temperature for 2 h. MeOH was evaporated and 
the product was extracted with EtOAc. The organic phase was washed with water and brine, and 
dried over Na2SO4. Solvent evaporation followed by flash chromatography (CH2Cl2:Hex:EtOAc, 
1:2:0.2) gave a light yellow solid (90 mg, 75% yield). 1H NMR (CDCl3): 8.64 (d, J = 8.4 Hz, 1 
H), 8.34 (d, J = 7.2 Hz, 1 H), 8.64 (d, J = 8.8 Hz, 1 H), 7.74-7.64 (m, 2 H), 7.39 (d, J = 7.6 Hz, 1 
H), 3.59 (t, J = 7.0 Hz, 2 H), 3.12 (t, J = 7.0 Hz, 2 H), 2.91 (s, 3 H), 2.91 (s, 6 H); 13C NMR 
(CDCl3): 149.8, 134.1, 131.7, 131.0, 130.4, 129.7, 129.2, 124.0, 120.7, 118.3, 60.6, 51.1, 50.4, 
45.1; IR 2916.9, 2421.7, 2130.7, 1571.2, 1465.2, 1166.6, 792.6, 743.8; MS (ES+) 333.9 (M+1)+. 
5-(N-(2-(Dimethylamino)ethyl)-N-methylamino)naphthalene-1-sulfonyl amide 88: 1H 
NMR (CDCl3): 8.51-8.46 (m, 2 H), 8.26 (d, J = 7.2 Hz, 1 H), 7.65-7.57 (m, 2 H), 7.40-7.38 (m, 1 
H), 3.52 (t, J = 6.0 Hz, 2 H), 3.13 (t, J = 6.0 Hz, 2 H), 2.84 (s, 3 H), 2.66 (s, 6 H); 13C NMR 
87 
(CDCl3): 149.8, 139.1, 130.6, 129.5, 128.7, 127.5, 127.0, 123.7, 120.8, 117.3, 60.1, 50.2, 49.9, 
43.5; MS (ES+) 308.0 (M+1)+. 
2.2.4 Conclusions 
Hcy is a very important biomarker for the diagnosis and prognosis of various diseases. 
However, due to the structural similarity of Hcy and Cys, direct detection of this biomarker still 
remains a major challenge. We have developed a novel redox sensitive fluorescent probe for 
quantitative Hcy analysis. The sensing reaction is selective for Hcy over other biological thiols 
such as Cys and GSH. In addition, a linear calibration curve could be obtained in both buffer and 
diluted deproteinized FBS with a detection limit at 10 µM. Endogenous Cys level fluctuation 
(200-250 µM) can also be tolerated to provide a good estimation of Hcy concentration. This 
probe will be very useful for the selective detection of Hcy in complex biological samples. 
2.2.5 Statements 
The much of the results in this chapter has been published in Chem. Commun. (Wang, 
K.;* Peng, H.;* Dai, C.; Williamson, S.; Wang, B., Redox-based selective fluorometric detection 
of homocysteine. Chem. Commun. 2014. 50 (89), 13668-13671, DOI: 10.1039/C4CC03677H) 
and J. Cell. Biochem. (Wang, K.; Peng, H.; Wang, B., Recent advances in thiol and sulfide 
reactive probes. J. Cell. Biochem. 2014, 115 (6), 1007-1022, DOI: 10.1002/jcb.24762). My 
contributions include fluorescence detection and quantitative evaluation of homocysteine probe. 
  
88 
REFERENCES 
1. Liu, J.; Lu, Y., Fast colorimetric sensing of adenosine and cocaine based on a general 
sensor design involving aptamers and nanoparticles. Angew. Chem. Int. Ed. 2006, 45 (1), 90-94. 
2. Drummond, T. G.; Hill, M. G.; Barton, J. K., Electrochemical DNA sensors. Nat. 
Biotechnol. 2003, 21, 1192-1199. 
3. Rothemund, P. W., Folding DNA to create nanoscale shapes and patterns. Nature 2006, 
440 (7082), 297-302. 
4. Long, X.; Thomas, A., Drug delivery trends in clinical trials and translational medicine: 
Challenges and opportunities in the delivery of nucleic acid-based therapeutics. J. Pharm. Sci. 
2011, 100, 38-52. 
5. Hurley, L. H., DNA and its associated processes as targets for cancer therapy. Nat. Rev. 
Cancer 2002, 2 (3), 188-200. 
6. Keefe, A. D.; Pai, S.; Ellington, A., Aptamers as therapeutics. Nat. Rev. Drug Discov. 
2010, 9 (7), 537-550. 
7. Kanan, M. W.; Rozenman, M. M.; Sakurai, K.; Snyder, T. M.; Liu, D. R., Reaction 
discovery enabled by DNA-templated synthesis and in vitro selection. Nature 2004, 431 (7008), 
545-549. 
8. Syed, M. A.; Pervaiz, S., Advances in aptamers. Oligonucleotides 2010, 20 (5), 215-224. 
9. Fang, X.; Tan, W., Aptamers generated from cell-SELEX for molecular medicine: a 
chemical biology approach. Accounts Chem. Res. 2009, 43, 48-57. 
10. Eaton, B. E.; Gold, L.; Hicke, B. J.; Janjić, N.; Jucker, F. M.; Sebesta, D. P.; Tarasow, T. 
M.; Willis, M. C.; Zichi, D. A., Post-SELEX combinatorial optimization of aptamers. Bioorg. 
Med. Chem. 1997, 5 (6), 1087-1096. 
89 
11. Sakthivel, K.; Barbas, C. F., Expanding the potential of DNA for binding and catalysis: 
highly functionalized dUTP derivatives that are substrates for thermostable DNA polymerases. 
Angew. Chem. Int. Ed. 1998, 37 (20), 2872-2875. 
12. Haque, M. M.; Peng, X., DNA-associated click chemistry. Sci. China Chem. 2013, 57 
(2), 215-231. 
13. Hollenstein, M., Nucleoside triphosphates building blocks for the modification of nucleic 
acids. Molecules 2012, 17 (11), 13569-13591. 
14. El-Sagheer, A. H.; Brown, T., Click chemistry with DNA. Chem. Soc. Rev. 2010, 39 (4), 
1388-1405. 
15. Sidman, R. L.; Miale, I. L.; Feder, N., Cell proliferation and migration in the primitive 
ependymal zone; an autoradiographic study of histogenesis in the nervous system. Exp. Neurol. 
Suppl. 1959, 1 (4), 322-333. 
16. Angevine Jr, J. B., Time of neuron origin in the hippocampal region: An 
autoradiographic study in the mouse. Exp. Neurol. Suppl. 1965, 11, 1-39. 
17. Schlessinger, A. R.; Cowan, W.; Gottlieb, D., An autoradiographic study of the time of 
origin and the pattern of granule cell migration in the dentate gyrus of the rat. J. Comp. Neurol. 
1975, 159 (2), 149-175. 
18. Altman, J.; Bayer, S. A., Mosaic organization of the hippocampal neuroepithelium and 
the multiple germinal sources of dentate granule cells. J. Comp. Neurol. 1990, 301 (3), 325-342. 
19. Taupin, P., BrdU immunohistochemistry for studying adult neurogenesis: paradigms, 
pitfalls, limitations, and validation. Brain ReS. Rev. 2007, 53 (1), 198-214. 
20. Gratzner, H. G., Monoclonal antibody to 5-bromo-and 5-iododeoxyuridine: a new reagent 
for detection of DNA replication. Science 1982, 218 (4571), 474-475. 
90 
21. Freese, A.; O'Rourke, D.; Judy, K.; O'Connor, M. J., The application of 5-
bromodeoxyuridine in the management of CNS tumors. J. Neurooncol. 1994, 20 (1), 81-95. 
22. Begg, A.; Hofland, I.; Van Der Pavert, I.; Van Der Schueren, B.; Haustermans, K., Use of 
thymidine analogues to indicate vascular perfusion in tumours. Brit. J. Cancer 2000, 83 (7), 899-
905. 
23. Neef, A. B.; Samain, F.; Luedtke, N. W., Metabolic labeling of DNA by purine analogues 
in vivo. ChemBioChem 2012, 13 (12), 1750-1753. 
24. Best, M. D., Click chemistry and bioorthogonal reactions: unprecedented selectivity in 
the labeling of biological molecules. Biochemistry 2009, 48 (28), 6571-6584. 
25. Sletten, E. M.; Bertozzi, C. R., Bioorthogonal chemistry: fishing for selectivity in a sea of 
functionality. Angew. Chem. Int. Ed. 2009, 48 (38), 6974-6998. 
26. Wang, Q.; Chan, T. R.; Hilgraf, R.; Fokin, V. V.; Sharpless, K. B.; Finn, M., 
Bioconjugation by copper (I)-catalyzed azide-alkyne [3+ 2] cycloaddition. J. Am. Chem. Soc. 
2003, 125 (11), 3192-3193. 
27. Saxon, E.; Bertozzi, C. R., Cell surface engineering by a modified Staudinger reaction. 
Science 2000, 287 (5460), 2007-2010. 
28. Baskin, J. M.; Prescher, J. A.; Laughlin, S. T.; Agard, N. J.; Chang, P. V.; Miller, I. A.; 
Lo, A.; Codelli, J. A.; Bertozzi, C. R., Copper-free click chemistry for dynamic in vivo imaging. 
P. Natl. Acad. Sci. 2007, 104 (43), 16793-16797. 
29. Ngo, J. T.; Champion, J. A.; Mahdavi, A.; Tanrikulu, I. C.; Beatty, K. E.; Connor, R. E.; 
Yoo, T. H.; Dieterich, D. C.; Schuman, E. M.; Tirrell, D. A., Cell-selective metabolic labeling of 
proteins. Nat. Chem. Biol. 2009, 5 (10), 715. 
91 
30. Jao, C. Y.; Salic, A., Exploring RNA transcription and turnover in vivo by using click 
chemistry. P. Natl. Acad. Sci. 2008, 105 (41), 15779-15784. 
31. Neef, A. B.; Schultz, C., Selective fluorescence labeling of lipids in living cells. Angew. 
Chem. Int. Ed. 2009, 48 (8), 1498-1500. 
32. Ning, X.; Guo, J.; Wolfert, M. A.; Boons, G. J., Visualizing Metabolically Labeled 
Glycoconjugates of Living Cells by Copper‐Free and Fast Huisgen Cycloadditions. Angew. 
Chem., Int. Ed. 2008, 47 (12), 2253-2255. 
33. Kolb, H. C.; Finn, M. G.; Sharpless, K. B., Click chemistry: diverse chemical function 
from a few good reactions. Angew. Chem. Int. Ed. 2001, 40 (11), 2004-2021. 
34. Rostovtsev, V. V.; Green, L. G.; Fokin, V. V.; Sharpless, K. B., A stepwise huisgen 
cycloaddition process: copper (I)- catalyzed regioselective “ligation” of azides and terminal 
alkynes. Angew. Chem. Int. Ed. 2002, 114 (14), 2708-2711. 
35. Seela, F.; Sirivolu, V., DNA containing side chains with terminal triple bonds: Base-pair 
stability and functionalization of alkynylated pyrimidines and 7-deazapurines. Chem. Biodivers. 
2006, 3 (5), 509-514. 
36. Burley, G.; Gierlich, J.; Mofid, M.; Nir, H.; Tal, S.; Eichen, Y.; Carell, T., Directed DNA 
metallization. J. Am. Chem. Soc. 2006, 128 (5), 1398-1399. 
37. Kolb, H.; Finn, M.; Sharpless, K., Click chemistry: diverse chemical function from a few 
good reactions. Angew. Chem. Int. Ed. 2001, 40 (11), 2004-2021. 
38. Tornøe, C. W.; Christensen, C.; Meldal, M., Peptidotriazoles on solid phase:[1, 2, 3]-
triazoles by regiospecific copper (I)-catalyzed 1, 3-dipolar cycloadditions of terminal alkynes to 
azides. J. Org. Chem. 2002, 67, 3057-3064. 
92 
39. John, C. J.; Carolyn, R. B., Cu-free click cycloaddition reactions in chemical biology. 
Chem. Soc. Rev. 2010, 39, 1272-1279. 
40. Selvaraj, R.; Fox, J. M., trans-Cyclooctene--a stable, voracious dienophile for 
bioorthogonal labeling. Curr. Opi. Chem. Bio. 2013, 17 (5), 753-760. 
41. Juliane, S.; Manfred, W.; Andres, J. s., Post-synthetic modification of DNA by inverse-
electron-demand Diels−Alder reaction. J. Am. Chem. Soc. 2010, 132, 8846-8847. 
42. Kennedy, D. C.; McKay, C. S.; Legault, M. C. B.; Danielson, D. C.; Blake, J. A.; 
Pegoraro, A. F.; Stolow, A.; Mester, Z.; Pezacki, J. P., Cellular consequences of copper 
complexes used to catalyze bioorthogonal click reactions. J. Am. Chem. Soc. 2011, 133 (44), 
17993-18001. 
43. Varizhuk, A. M.; Kaluzhny, D. N.; Novikov, R. A.; Chizhov, A. O.; Smirnov, I. P.; 
Chuvilin, A. N.; Tatarinova, O. N.; Fisunov, G. Y.; Pozmogova, G. E.; Florentiev, V. L., 
Synthesis of triazole-linked oligonucleotides with high affinity to DNA complements and an 
analysis of their compatibility with biosystems. J. Org. Chem. 2013, 78 (12), 5964-5969. 
44. Pujari, S. S.; Ingale, S. A.; Seela, F., High-density functionalization and cross-linking of 
DNA: “click” and “bis-click” cycloadditions performed on alkynylated oligonucleotides with 
fluorogenic anthracene azides. Bioconjugate Chem. 2014, 25 (10), 1855-1870. 
45. Arndt, S.; Wagenknecht, H.-A., “Photoclick” postsynthetic modification of DNA. Angew. 
Chem. Int. Ed 2014, Early View. 
46. Neef, A. B.; Luedtke, N. W., An azide-modified nucleoside for metabolic labeling of 
DNA. ChemBioChem 2014, 15, 789-793. 
93 
47. Bußkamp, H.; Ellen, B.; Niederwieser, A.; Abdel-Rahman, O. S.; Winter, R. F.; 
Wittmann, V.; Marx, A., Efficient labelling of enzymatically synthesized vinyl-modified DNA 
by an inverse-electron-demand Diels–Alder reaction. Chem. Commun. 2014, 50, 10827-10829. 
48. Stubinitzky, C.; Cserép, G. B.; Bätzner, E.; Kele, P.; Wagenknecht, H.-A., 2′-
Deoxyuridine conjugated with a reactive monobenzocyclooctyne as a DNA building block for 
copper-free click-type postsynthetic modification of DNA. Chem. Commun. 2014, 50, 11218-
11221. 
49. Pyka, A. M.; Domnick, C.; Braun, F., Diels–Alder cycloadditions on synthetic RNA in 
mammalian cells. Bioconjugate Chem. 2014, 25, 1438-1443. 
50. Rieder, U.; Luedtke, N. W., Alkene-tetrazine ligation for imaging cellular DNA. Angew. 
Chem. Int. Ed 2014, 126 (35), 9322-9326. 
51. Ötvös, L.; Sági, J.; Kovács, T.; Walker, R. T., Substrate specificity of DNA polymerases 
I. Enzyme-catalysed incorporation of 5-(1-alkenyl)-2′-deoxyuridines into DNA. Nucleic Acids 
Res. 1987, 15 (4), 1763-1777. 
52. Kovács, T.; Ötvös, L., Simple synthesis of 5-vinyl-and5-ethynyl-2′-deoxyuridine-5′-
triphosphates. Tetrahedron Lett. 1988, 29 (36), 4525-4528. 
53. Gramlich, P. M.; Wirges, C. T.; Manetto, A.; Carell, T., Postsynthetic DNA modification 
through the copper-catalyzed azide-alkyne cycloaddition reaction. Angew. Chem. Int. Ed. 2008, 
47 (44), 8350-8358. 
54. Lallana, E.; Riguera, R.; Fernandez‐Megia, E., Reliable and efficient procedures for the 
conjugation of biomolecules through Huisgen azide-alkyne cycloadditions. Angew. Chem. Int. 
Ed. 2011, 50 (38), 8794-8804. 
94 
55. van Delft, P.; Meeuwenoord, N. J.; Hoogendoorn, S.; Dinkelaar, J.; Overkleeft, H. S.; van 
der Marel, G. A.; Filippov, D. V., Synthesis of oligoribonucleic acid conjugates using a 
cyclooctyne phosphoramidite. Org. Lett. 2010, 12 (23), 5486-5489. 
56. Jayaprakash, K. N.; Peng, C. G.; Butler, D.; Varghese, J. P.; Maier, M. A.; Rajeev, K. G.; 
Manoharan, M., Non-nucleoside building blocks for copper-assisted and copper-free click 
chemistry for the efficient synthesis of RNA conjugates. Org. Lett. 2010, 12 (23), 5410-5413. 
57. Shelbourne, M.; Chen, X.; Brown, T.; El-Sagheer, A. H., Fast copper-free click DNA 
ligation by the ring-strain promoted alkyne-azide cycloaddition reaction. Chem. Commun. 2011, 
47 (22), 6257-6259. 
58. Shelbourne, M.; Brown, T.; El-Sagheer, A. H.; Brown, T., Fast and efficient DNA 
crosslinking and multiple orthogonal labelling by copper-free click chemistry. Chem. Commun. 
2012, 48 (91), 11184-11186. 
59. Ren, X.; Gerowska, M.; El-Sagheer, A. H.; Brown, T., Enzymatic incorporation and 
fluorescent labelling of cyclooctyne-modified deoxyuridine triphosphates in DNA. Bioorg. Med. 
Chem. 2014, 22 (16), 4384-4390. 
60. Jäger, S.; Rasched, G.; Kornreich-Leshem, H.; Engeser, M.; Thum, O.; Famulok, M., A 
versatile toolbox for variable DNA functionalization at high density. J. Am. Chem. Soc. 2005, 
127 (43), 15071-15082. 
61. Kool, E. T., Replacing the nucleohases in DNA with designer molecules. Acc. Chem. 
Res. 2002, 35 (11), 936-943. 
62. Wilson, J. N.; Kool, E. T., Fluorescent DNA base replacements: reporters and sensors for 
biological systems. Org. Biomol. Chem. 2006, 4 (23), 4265-4274. 
95 
63. Greco, N. J.; Tor, Y., Simple fluorescent pyrimidine analogues detect the presence of 
DNA abasic sites. J. Am. Chem. Soc. 2005, 127 (31), 10784-10785. 
64. Nadler, A.; Strohmeier, J.; Diederichsen, U., 8-Vinyl-2′-deoxyguanosine as a fluorescent 
2′-deoxyguanosine mimic for investigating DNA hybridization and topology. Angew. Chem. Int. 
Ed. 2011, 50 (23), 5392-5396. 
65. Müllar, S.; Strohmeier, J.; Diederichsen, U., 8-Vinylguanine nucleo amino acid: a 
fluorescent PNA building block. Org. Lett. 2012, 14 (6), 1382-1385. 
66. Holzberger, B.; Strohmeier, J.; Siegmund, V.; Diederichsen, U.; Marx, A., Enzymatic 
synthesis of 8-vinyl- and 8-styryl-2'-deoxyguanosine modified DNA--novel fluorescent 
molecular probes. Bioorg. Med. Chem. Lett. 2012, 22 (9), 3136-3139. 
67. Ogasawara, S.; Saito, I.; Maeda, M., Synthesis and reversible photoisomerization of 
photoswitchable nucleoside, 8-styryl-2′-deoxyguanosine. Tetrahedron Lett. 2008, 49 (15), 2479-
2482. 
68. Bußkamp, H.; Batroff, E.; Niederwieser, A.; Abdel-Rahman, O. S.; Winter, R. F.; 
Wittmann, V.; Marx, A., Efficient labelling of enzymatically synthesized vinyl-modified DNA 
by an inverse-electron-demand Diels–Alder reaction. Chem. Commun. 2014, 50 (74), 10827-
10829. 
69. Seela, F.; Zulauf, M.; Sauer, M.; Deimel, M., 7-Substituted 7-deaza-2′-deoxyadenosines 
and 8-aza-7-deaza-2′-deoxyadenosines: fluorescence of DNA-base analogues induced by the 7-
alkynyl side chain. Helv. Chim. Acta 2000, 83 (5), 910-927. 
70. Riedl, J.; Pohl, R.; Ernsting, N. P.; Orsag, P.; Fojta, M.; Hocek, M., Labelling of 
nucleosides and oligonucleotides by solvatochromic 4-aminophthalimide fluorophore for 
studying DNA-protein interactions. Chem. Sci. 2012, 3 (9), 2797-2806. 
96 
71. Riedl, J.; Ménová, P.; Pohl, R.; Orság, P.; Fojta, M.; Hocek, M., GFP-like fluorophores 
as DNA labels for studying DNA-protein interactions. J. Org. Chem. 2012, 77 (18), 8287-8293. 
72. Ormo, M.; Cubitt, A. B.; Kallio, K.; Gross, L. A.; Tsien, R. Y.; Remington, S. J., Crystal 
structure of the Aequorea victoria green fluorescent protein. Science 1996, 273 (5280), 1392-
1395. 
73. Reid, B. G.; Flynn, G. C., Chromophore formation in green fluorescent protein. 
Biochemistry 1997, 36 (22), 6786-91. 
74. Niwa, H.; Inouye, S.; Hirano, T.; Matsuno, T.; Kojima, S.; Kubota, M.; Ohashi, M.; 
Tsuji, F. I., Chemical nature of the light emitter of the Aequorea green fluorescent protein. P. 
Natl. Acad. Sci. 1996, 93 (24), 13617-22. 
75. Paige, J. S.; Wu, K. Y.; Jaffrey, S. R., RNA mimics of green fluorescent protein. Science 
2011, 333 (6042), 642-646. 
76. Brown, J. A.; Suo, Z., Unlocking the sugar "steric gate" of DNA polymerases. 
Biochemistry 2011, 50 (7), 1135-1142. 
77. Berndl, S.; Herzig, N.; Kele, P.; Lachmann, D.; Li, X.; Wolfbeis, O. S.; Wagenknecht, 
H.-A., Comparison of a nucleosidic vs non-nucleosidic postsynthetic “click” modification of 
DNA with base-labile fluorescent probes. Bioconjugate Chem. 2009, 20 (3), 558-564. 
78. Wenge, U.; Ehrenschwender, T.; Wagenknecht, H.-A., Synthesis of 2′-O-propargyl 
nucleoside triphosphates for enzymatic oligonucleotide preparation and “click” modification of 
DNA with nile red as fluorescent porobe. Bioconjugate Chem. 2013, 24 (3), 301-304. 
79. Krishna, H.; Caruthers, M. H., Alkynyl phosphonate DNA: a versatile “click”able 
backbone for DNA-based biological applications. J. Am. Chem. Soc. 2012, 134 (28), 11618-
11631. 
97 
80. Paul, S.; Roy, S.; Monfregola, L.; Shang, S.; Shoemaker, R.; Caruthers, M. H., Oxidative 
substitution of boranephosphonate diesters as a route to post-synthetically modified DNA. J. Am. 
Chem. Soc. 2015, 137 (9), 3253-3264. 
81. Stubinitzky, C.; Cserép, G. B.; Bätzner, E.; Kele, P.; Wagenknecht, H.-A., 2′-
Deoxyuridine conjugated with a reactive monobenzocyclooctyne as a DNA building block for 
copper-free click-type postsynthetic modification of DNA. Chem. Commun. 2014, 50 (76), 
11218-11221. 
82. Arndt, S.; Wagenknecht, H.-A., “Photoclick” postsynthetic modification of DNA. Angew. 
Chem. Int. Ed. 2014, 53 (52), 14580-14582. 
83. Tuerk, C.; Gold, L., Systematic evolution of ligands by exponential enrichment: RNA 
ligands to bacteriophage T4 DNA polymerase. Science 1990, 249 (4968), 505-10. 
84. Ellington, A. D.; Szostak, J. W., In vitro selection of RNA molecules that bind specific 
ligands. Nature 1990, 346 (6287), 818-22. 
85. Bruno, J., A review of therapeutic aptamer conjugates with emphasis on new approaches. 
Pharmaceuticals 2013, 6 (3), 340-357. 
86. Germer, K.; Leonard, M.; Zhang, X., RNA aptamers and their therapeutic and diagnostic 
applications. Int. J. Biochem. Mol. Biol. 2013, 4 (1), 27-40. 
87. Hong, P.; Li, W.; Li, J., Applications of aptasensors in clinical diagnostics. Sensors 
(Basel) 2012, 12 (2), 1181-1193. 
88. Morris, K. N.; Jensen, K. B.; Julin, C. M.; Weil, M.; Gold, L., High affinity ligands from 
in vitro selection: Complex targets. Proc Natl Acad Sci U S A 1998, 95 (6), 2902-2907. 
98 
89. Blank, M.; Weinschenk, T.; Priemer, M.; Schluesener, H., Systematic evolution of a 
DNA aptamer binding to rat brain tumor microvessels: selective targeting of endorhelial 
regulatory protein pigpen. J. Biol. Chem. 2001, 276 (19), 16464-16468. 
90. Wang, C.; Zhang, M.; Yang, G.; Zhang, D.; Ding, H.; Wang, H.; Fan, M.; Shen, B.; 
Shao, N., Single-stranded DNA aptamers that bind differentiated but not parental cells: 
subtractive systematic evolution of ligands by exponential enrichment. J. Biotech. 2003, 102 (1), 
15-22. 
91. Shangguan, D.; Li, Y.; Tang, Z.; Cao, Z. C.; Chen, H. W.; Mallikaratchy, P.; Sefah, K.; 
Yang, C. J.; Tan, W., Aptamers evolved from live cells as effective molecular probes for cancer 
study. Proc Natl Acad Sci U S A 2006, 103 (32), 11838-43. 
92. Subramanian, N.; Sreemanthula, J. B.; Balaji, B.; Kanwar, J. R.; Biswas, J.; 
Krishnakumar, S., A strain-promoted alkyne–azide cycloaddition (SPAAC) reaction of a novel 
EpCAM aptamer–fluorescent conjugate for imaging of cancer cells. Chem. Commun. 2014, 50, 
11810-11813. 
93. Song, Y.; Zhu, Z.; An, Y.; Zhang, W.; Zhang, H.; Liu, D.; Yu, C.; Duan, W.; Yang, C. J., 
Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and 
circulating tumor cell capture. Anal. Chem. 2013, 85 (8), 4141-4149. 
94. Yoon, J.; Czarnik, A. W., Fluorescent Chemosensors of Carbohydrates. A Means of 
Chemically Communicating the Binding of Polyols in Water Based on Chelation-Enhanced 
Quenching. J. Am. Chem. Soc. 1992, 114, 5874-5875. 
95. James, T. D.; Sandanayake, K. R. A. S.; Iguchi, R.; Shinkai, S., Novel saccharide-
photoinduced electron transfer sensors based on the interaction of boronic acid and amine. J. Am. 
Chem. Soc. 1995, 117 (35), 8982-8987. 
99 
96. Asher, S. A.; Alexeev, V. L.; Goponenko, A. V.; Sharma, A. C.; Lednev, I. K.; Wilcox, 
C. S.; Finegold, D. N., Photonic crystal carbohydrate sensors: low ionic strength sugar sensing. J 
Am Chem Soc 2003, 125 (11), 3322-3329. 
97. Jin, S.; Cheng, Y.; Reid, S.; Li, M.; Wang, B., Carbohydrate recognition by 
boronolectins, small molecules, and lectins. Med. Res. Rev. 2010, 30 (2), 171-257. 
98. Yan, J.; Fang, H.; Wang, B., Boronolectins and Fluorescent Boronolectins-An 
Examination of the Detailed Chemistry Issues Important for their Design. Med. Res. Rev. 2005, 
25, 490-520. 
99. Striegler, S., Selective carbohydrate recognition by synthetic receptors in aqueous 
solution. Curr. Org. Chem. 2003, 7 (1), 81-102. 
100. James, T. D.; Shinkai, S., Artificial Receptors as Chemosensors for Carbohydrates. Top. 
Curr. Chem. 2002, 218, 159-200. 
101. Springsteen, G.; Wang, B., A detailed examination of boronic acid–diol complexation. 
Tetrahedron 2002, 58 (26), 5291-5300. 
102. Gamsey, S.; Miller, A.; Olmstead, M. M.; Beavers, C. M.; Hirayama, L. C.; Pradhan, S.; 
Wessling, R. A.; Singaram, B., Boronic acid-based bipyridinium salts as tunable receptors for 
monosaccharides and α-hydroxycarboxylates. J. Am. Chem. Soc. 2007, 129 (5), 1278-1286. 
103. Wang, Z.; Zhang, D.; Zhu, D., A new saccharide sensor based on a 
tetrathiafulvalene−anthracene dyad with a boronic acid group. J. Org. Chem. 2005, 70 (14), 
5729-5732. 
104. Mohler, L. K.; Czarnik, A. W., .alpha.-Amino acid chelative complexation by an 
arylboronic acid. J. Am. Chem. Soc. 1993, 115 (15), 7037-7038. 
100 
105. Aharoni, R.; Bronstheyn, M.; Jabbour, A.; Zaks, B.; Srebnik, M.; Steinberg, D., 
Oxazaborolidine derivatives inducing autoinducer-2 signal transduction in Vibrio harveyi. 
Bioorg. Med. Chem. 2008, 16 (4), 1596-1604. 
106. Jabbour, A.; Steinberg, D.; Dembitsky, V. M.; Moussaieff, A.; Zaks, B.; Srebnik, M., 
Synthesis and evaluation of oxazaborolidines for antibacterial activity against streptococcus 
mutans. J. Med. Chem. 2004, 47 (10), 2409-2410. 
107. Farr-Jones, S.; Smith, S. O.; Kettner, C. A.; Griffin, R. G.; Bachovchin, W. W., Crystal 
versus solution structure of enzymes: NMR spectroscopy of a peptide boronic acid-serine 
protease complex in the crystalline state. Proc Natl Acad Sci U S A 1989, 86 (18), 6922-4. 
108. Snow, R. J.; Bachovchin, W. W.; Barton, R. W.; Campbell, S. J.; Coutts, S. J.; Freeman, 
D. M.; Gutheil, W. G.; Kelly, T. A.; Kennedy, C. A., Studies on proline boronic acid dipeptide 
inhibitors of dipeptidyl peptidase IV: identification of a cyclic species containing a B-N bond. J. 
Am. Chem. Soc. 1994, 116 (24), 10860-10869. 
109. Dowlut, M.; Hall, D. G., An improved class of sugar-binding boronic acids, soluble and 
capable of complexing glycosides in neutral water. J. Am. Chem. Soc. 2006, 128 (13), 4226-
4227. 
110. Badugu, R.; Lakowicz, J. R.; Geddes, C. D., Excitation and emission wavelength 
ratiometric cyanide-sensitive probes for physiological sensing. Anal Biochem 2004, 327 (1), 82-
90. 
111. Badugu, R.; Lakowicz, J. R.; Geddes, C. D., Cyanide-sensitive fluorescent probes. Dyes 
and Pigments 2005, 64 (1), 49-55. 
112. R. Cooper, C.; Spencer, N.; D. James, T., Selective fluorescence detection of fluoride 
using boronic acids. Chem. Commun. 1998,  (13), 1365-1366. 
101 
113. DiCesare, N.; Lakowicz, J. R., New sensitive and selective fluorescent probes for fluoride 
using boronic acids. Anal. Biochem. 2002, 301 (1), 111-116. 
114. Yoon, J.; Czarnik, A. W., Fluorescent chemosensors of carbohydrates. A means of 
chemically communicating the binding of polyols in water based on chelation-enhanced 
quenching. J. Am. Chem. Soc. 1992, 114 (14), 5874-5875. 
115. Kondo, K.; Shiomi, Y.; Saisho, M.; Harada, T.; Shinkai, S., Specific Complexation of 
Disaccharides with Diphenyl-3,3'-diboronic Acid that Can Be Detected by Circular Dichroism. 
Tetrahedron 1992, 48, 8239-8252. 
116. Eggert, H.; Frederiksen, J.; Morin, C.; Norrild, J. C., A new glucose-selective fluorescent 
bisboronic acid. first report of strong α-furanose complexation in aqueous solution at 
physiological pH. J. Org. Chem. 1999, 64 (11), 3846-3852. 
117. James, T. D.; Sandanayake, K. R. A. S.; Shinkai, S., Saccharide sensing with molecular 
receptors based on boronic acid. Angew. Chem. Int. Ed. 1996, 35 (17), 1910-1922. 
118. Wang, W.; Gao, S.; Wang, B., Building fluorescent sensors by template polymerization:  
the preparation of a fluorescent sensor for d-fructose. Org. Lett. 1999, 1 (8), 1209-1212. 
119. Gao, X.; Zhang, Y.; Wang, B., New boronic acid fluorescent reporter compounds. 2. a 
naphthalene-based on−off sensor functional at physiological pH. Org. Lett. 2003, 5 (24), 4615-
4618. 
120. Fang, H.; Kaur, G.; Wang, B., Progress in boronic acid-based fluorescent glucose 
sensors. J. Fluorescence 2004, 14 (5), 481-489. 
121. Westmark, P. R.; Gardiner, S. J.; Smith, B. D., Selective monosaccharide transport 
through lipid bilayers using boronic acid carriers. J. Am. Chem. Soc. 1996, 118 (45), 11093-
11100. 
102 
122. Draffin, S. P.; Duggan, P. J.; Duggan, S. A. M., Highly fructose selective transport 
promoted by boronic acids based on a pentaerythritol core. Org. Lett. 2001, 3 (6), 917-920. 
123. Gardiner, S. J.; Smith, B. D.; Duggan, P. J.; Karpa, M. J.; Griffin, G. J., Selective fructose 
transport through supported liquid membranes containing diboronic acid or conjugated 
monoboronic acid-quaternary ammonium carriers. Tetrahedron 1999, 55 (10), 2857-2864. 
124. Karpa, M. J.; Duggan, P. J.; Griffin, G. J.; Freudigmann, S. J., Competitive transport of 
reducing sugars through a lipophilic membrane facilitated by aryl boron acids. Tetrahedron 
1997, 53 (10), 3669-3678. 
125. Mohler, L. K.; Czarnik, A. W., Ribonucleoside membrane transport by a new class of 
synthetic carrier. J. Am. Chem. Soc. 1993, 115 (7), 2998-2999. 
126. Riggs, J. A.; Hossler, K. A.; Smith, B. D.; Karpa, M. J.; Griffin, G.; Duggan, P. J., 
Nucleotide carrier mixture with transport selectivity for ribonucleoside-5′-phosphates. 
Tetrahedron Lett. 1996, 37 (35), 6303-6306. 
127. Paugam, M.-F.; Bien, J. T.; Smith, B. D.; Chrisstoffels, L. A. J.; de Jong, F.; Reinhoudt, 
D. N., Facilitated catecholamine transport through bulk and polymer-supported liquid 
membranes. J. Am. Chem. Soc. 1996, 118 (41), 9820-9825. 
128. Liu, X.-C.; Hubbard, J. L.; Scouten, W. H., Synthesis and structural investigation of two 
potential boronate affinity chromatography ligands catechol [2-
(diisopropylamino)carbonyl]phenylboronate and catechol [2-(diethylamino)carbonyl, 4-
methyl]phenylboronate. J. Organomet. Chem. 1995, 493 (1–2), 91-94. 
129. Adamek, V.; Liu, X.-C.; Zhang, Y. A.; Adamkova, K.; Scouten, W. H., New aliphatic 
boronate ligands for affinity chromatography. J. Chromatogr. A 1992, 625 (2), 91-99. 
103 
130. Westmark, P. R.; Valencia, L. S.; Smith, B. D., Influence of eluent anions in boronate 
affinity chromatography. J. Chromatogr. A 1994, 664 (1), 123-128. 
131. Springsteen, G.; Wang, B., Alizarin Red S. as a general optical reporter for studying the 
binding of boronic acids with carbohydrates. Chem. Commun. 2001, 1608-1609. 
132. Cheng, Y.; Ni, N.; Yang, W.; Wang, B., A new class of fluorescent boronic acids that 
have extraordinarily high affinities for diols in aqueous solution at physiological pH. Chem. Eur. 
J. 2010, 16 (45), 13528-13538. 
133. Akay, S.; Yang, W. Q.; Wang, J. F.; Lin, L.; Wang, B. H., Synthesis and evaluation of 
dual wavelength fluorescent benzo[b]thiophene boronic acid derivatives for sugar sensing. 
Chemical Biology & Drug Design 2007, 70 (4), 279-289. 
134. Han, F.; Chi, L. N.; Liang, X. F.; Ji, S. M.; Liu, S. S.; Zhou, F. K.; Wu, Y. B.; Han, K. L.; 
Zhao, J. Z.; James, T. D., 3,6-Disubstituted Carbazole-Based Bisboronic Acids with Unusual 
Fluorescence Transduction as Enantioselective Fluorescent Chemosensors for Tartaric Acid. J. 
Org. Chem. 2009, 74 (3), 1333-1336. 
135. Jin, S.; Wang, J. F.; Li, M. Y.; Wang, B. H., Synthesis, Evaluation, and Computational 
Studies of Naphthalimide-based Long-wavelength Fluorescent Boronic Acid Reporters. Chem. 
Eur. J. 2008, 14 (9), 2795-2804. 
136. Jin, S.; Zhu, C. Y.; Li, M. Y.; Wang, B. H., Identification of the First Fluorescent alpha-
Amidoboronic Acids that Change Fluorescent Properties upon Sugar Binding. Bioorg. Med. 
Chem. Lett. 2009, 19 (6), 1596-1599. 
137. Wang, J. F.; Jin, S.; Akay, S.; Wang, B. H., Design and synthesis of long-wavelength 
fluorescent boronic acid reporter compounds. European Journal of Organic Chemistry 2007,  
(13), 2091-2099. 
104 
138. Springsteen, G.; Wang, B., A detailed examination of boronic acid–diol complexation. 
Tetrahedron 2002, 58, 5291-5300. 
139. Lin, N.; Yan, J.; Huang, Z.; Altier, C.; Li, M.; Carrasco, N.; Suyemoto, M.; Johnston, L.; 
Wang, S.; Wang, Q.; Fang, H.; Caton-Williams, J.; Wang, B., Design and synthesis of boronic-
acid-labeled thymidine triphosphate for incorporation into DNA. Nucleic Acids Res. 2006, 35 
(4), 1222-1229. 
140. Li, M.; Lin, N.; Huang, Z.; Du, L.; Altier, C.; Fang, H.; Wang, B., Selecting aptamers for 
a glycoprotein through the incorporation of the boronic acid moiety. J. Am. Chem. Soc. 2008, 
130 (38), 12636-12638. 
141. Yang, X.; Dai, C.; Molina, A. D. C.; Wang, B., Boronic acid-modified DNA that changes 
fluorescent properties upon carbohydrate binding. Chem. Commun. 2010, 46, 1073-1075. 
142. Dai, C.; Wang, L.; Sheng, J.; Peng, H.; Draganov, A.; Huang, Z.; Wang, B., The first 
chemical synthesis of boronic acid-modified DNA through a copper-free click reaction. Chem. 
Commun. 2011, 47 (12), 3598-3600. 
143. Cheng, Y.; Dai, C.; Peng, H.; Zheng, S.; Jin, S.; Wang, B., Design, synthesis, and 
polymerase catalyzed incorporation of Click modified boronic acid–TTP analogues. Chem. 
Asian. J. 2011, 6 (10), 2747-2752. 
144. Cheng, Y.; Peng, H.; Chen, W.; Ni, N.; Ke, B.; Dai, C.; Wang, B., Rapid and specific 
post-synthesis modification of DNA through a biocompatible condensation of 1,2-aminothiols 
with 2-cyanobenzothiazole. Chem. Eur. J. 2013, 19 (12), 4036-4042. 
145. Blackman, M.; Royzen, M.; Fox, J., Tetrazine ligation: fast bioconjugation based on 
inverse-electron-demand Diels-Alder reactivity. J. Am. Chem. Soc. 2008, 130 (41), 13518-13519. 
105 
146. Taylor, M. T.; Blackman, M. L.; Dmitrenko, O.; Fox, J. M., Design and synthesis of 
highly reactive dienophiles for the tetrazine–trans-cyclooctene Ligation. J. Am. Chem. Soc. 
2011, 133, 9646-9649. 
147. Chen, W.; Wang, D.; Dai, C.; Hamelberg, D.; Wang, B., Clicking 1, 2, 4, 5-tetrazine and 
cyclooctynes with tunable reaction rates. Chem. Commun. 2012, 48, 1736-1738. 
148. Kufe, D. W., Mucins in cancer: function, prognosis and therapy. Nat. Rev. Cancer 2009, 
9 (12), 874-885. 
149. Maher, D. M.; Gupta, B. K.; Nagata, S.; Jaggi, M.; Chauhan, S. C., Mucin 13: structure, 
function, and potential roles in cancer pathogenesis. Mol. Cancer Res. 2011, 9 (5), 531-7. 
150. Chauhan, S. C.; Ebeling, M. C.; Maher, D. M.; Koch, M. D.; Watanabe, A.; Aburatani, 
H.; Lio, Y.; Jaggi, M., MUC13 mucin augments pancreatic tumorigenesis. Mol. Cancer Ther. 
2012, 11 (1), 24-33. 
151. Royzen, M.; Yap, G. P.; Fox, J. M., A photochemical synthesis of functionalized trans-
cyclooctenes driven by metal complexation. J. Am. Chem. Soc. 2008, 130 (12), 3760-3761. 
152. Marika, K.; Mia, H.; Pasi, V.; Harri, L. n., Synthesis of oligonucleotide glycoconjugates 
using sequential click and oximation ligations. Bioconjugate Chem. 2010, 21 (4), 748-755. 
153. Kuwahara, M.; Nagashima, J.-i.; Hasegawa, M.; Tamura, T.; Kitagata, R.; Hanawa, K.; 
Hososhima, S.-i.; Kasamatsu, T.; Ozaki, H.; Sawai, H., Systematic characterization of 2'-
deoxynucleoside- 5'-triphosphate analogs as substrates for DNA polymerases by polymerase 
chain reaction and kinetic studies on enzymatic production of modified DNA. Nucleic Acids Res. 
2005, 34 (19), 5383-5394. 
154. Henry, G. K., Electrophilic displacement reactions. III. kinetics of the reaction between 
hydrogen peroxide and benzeneboronic acid 1. J. Am. Chem. Soc. 1954, 76, 870-874. 
106 
155. Ji, K.; Lim, W. S.; Li, S. F. Y.; Bhakoo, K., … cell-SELEX method to generate a DNA 
aptamer to recognize inflamed human aortic endothelial cells as a potential in vivo molecular 
probe for atherosclerosis plaque …. Anal. Bioanal. Chem. 2013, 405 (21), 6853-6861. 
156. Ji, K.; de Carvalho, L. P.; Bi, X.; Seneviratnankn, A.; Bhakoo, K.; Chan, M.; Li, S. F. Y., 
Highly sensitive and quantitative human thrombospondin-1 detection by an M55 aptasensor and 
clinical validation in patients with atherosclerotic disease. Biosens. Bioelectron. 2014, 55, 405-
411. 
157. Kang, J.; Kim, M.; Chang, S.; Sim, S.; Jo, Y., CCAAT box is required for the induction 
of human thrombospondin 1 gene by trichostatin A. J. Cell. Biochem. 2008, 104 (4), 1192-1203. 
158. Wang, K.; Wang, D.; Ji, K.; Chen, W.; Zheng, Y.; Dai, C.; Wang, B., Post-synthesis 
DNA modifications using a trans-cyclooctene click handle. Org. Biomol. Chem. 2015, 13 (3), 
909-915. 
159. Patel, D. J.; Suri, A. K.; Jiang, F.; Jiang, L.; Fan, P.; Kumar, R. A.; Nonin, S., Structure, 
recognition and adaptive binding in RNA aptamer complexes1. J. Mol. Biol. 1997, 272 (5), 645-
664. 
160. Rodesch, M. J.; Ozers*, M. S.; Warren, C. L., Macromolecular Interactions: Aptamers. In 
eLS, John Wiley & Sons, Ltd: 2001. 
161. Sefah, K.; Shangguan, D.; Xiong, X.; O'Donoghue, M. B.; Tan, W., Development of 
DNA aptamers using Cell-SELEX. Nat. Protoc. 2010, 5 (6), 1169-1185. 
162. Avci-Adali, M.; Paul, A.; Wilhelm, N.; Ziemer, G.; Wendel, H. P., Upgrading SELEX 
technology by using lambda exonuclease digestion for single-stranded DNA generation. 
Molecules 2009, 15 (1), 1. 
107 
163. Gyllensten, U. B.; Erlich, H. A., Generation of single-stranded DNA by the polymerase 
chain reaction and its application to direct sequencing of the HLA-DQA locus. Proc Natl Acad 
Sci U S A 1988, 85 (20), 7652-7656. 
164. Paul, A.; Avci-Adali, M.; Ziemer, G.; Wendel, H. P., Streptavidin-coated magnetic beads 
for DNA strand separation implicate a multitude of problems during cell-SELEX. 
Oligonucleotides 2009, 19 (3), 243-54. 
165. Ji, K.; Lim, W.; Li, S.; Bhakoo, K., A two-step stimulus-response cell-SELEX method to 
generate a DNA aptamer to recognize inflamed human aortic endothelial cells as a potential in 
vivo molecular probe for atherosclerosis plaque detection. Anal. Bioanal. Chem. 2013, 405 (21), 
6853-6861. 
166. Marimuthu, C.; Tang, T.-H.; Tominaga, J.; Tan, S.-C.; Gopinath, S. C. B., Single-
stranded DNA (ssDNA) production in DNA aptamer generation. Analyst 2012, 137 (6), 1307-
1315. 
167. Deer, E. L.; Gonzalez-Hernandez, J.; Coursen, J. D.; Shea, J. E.; Ngatia, J.; Scaife, C. L.; 
Firpo, M. A.; Mulvihill, S. J., Phenotype and genotype of pancreatic cancer cell lines. Pancreas 
2010, 39 (4), 425-35. 
168. Sefah, K.; Bae, K. M.; Phillips, J. A.; Siemann, D. W.; Su, Z.; McClellan, S.; Vieweg, J.; 
Tan, W., Cell-based selection provides novel molecular probes for cancer stem cells. Int. J. 
Cancer 2013, 132 (11), 2578-88. 
169. Graham, J. C.; Zarbl, H., Use of cell-SELEX to generate DNA aptamers as molecular 
probes of HPV-associated cervical cancer cells. PLoS One 2012, 7 (4), e36103. 
108 
170. Kang, D.; Wang, J.; Zhang, W.; Song, Y.; Li, X.; Zou, Y.; Zhu, M.; Zhu, Z.; Chen, F.; 
Yang, C. J., Selection of DNA aptamers against glioblastoma cells with high affinity and 
specificity. PLoS One 2012, 7 (10), e42731. 
171. Stellwagen, N. C.; Stellwagen, E., Effect of the matrix on DNA electrophoretic mobility. 
J. Chromatogr. A 2009, 1216 (10), 1917-1929. 
172. Lang, K.; Davis, L.; Wallace, S.; Mahesh, M.; Cox, D. J.; Blackman, M. L.; Fox, J. M.; 
Chin, J. W., Genetic encoding of bicyclononynes and trans-cyclooctenes for site-specific protein 
labeling in vitro and in live mammalian cells via rapid fluorogenic Diels–Alder reactions. J. Am. 
Chem. Soc. 2012, 134 (25), 10317-10320. 
173. Nuzzolo, M.; Grabulosa, A.; Slawin, A. M. Z.; Meeuwenoord, N.; Marel, G. A.; Kamer, 
P., Functionalization of mono- and oligonucleotides with phosphane ligands by amide bond 
formation. European Journal of Organic Chemistry 2010, 3229-3236. 
174. Wang, D.; Chen, W.; Zheng, Y.; Dai, C.; Wang, K.; Ke, B.; Wang, B., 3, 6-Substituted-1, 
2, 4, 5-tetrazines: tuning reaction rates for staged labeling applications. Org. Biomol. Chem. 
2014, 12, 3950-3955. 
175. Beckmann, H. S. G.; Niederwieser, A.; Wiessler, M.; Wittmann, V., Preparation of 
carbohydrate arrays by using Diels-Alder reactions with inverse electron demand. Chem. Eur. J 
2012, 18 (21), 6548-6554. 
176. Smirnov, D.; Dhall, A.; Sivanesam, K.; Sharar, R. J.; Chatterjee, C., Fluorescent probes 
reveal a minimal ligase recognition motif in the prokaryotic ubiquitin-like protein from 
mycobacterium tuberculosis. J. Am. Chem. Soc. 2013, 135 (8), 2887-2890. 
177. Moncada, S.; Palmer, R. M.; Higgs, E. A., Nitric oxide: physiology, pathophysiology, 
and pharmacology. Pharmacol. Rev. 1991, 43 (2), 109-42. 
109 
178. Verma, A.; Hirsch, D. J.; Glatt, C. E.; Ronnett, G. V.; Snyder, S. H., Carbon monoxide: a 
putative neural messenger. Science 1993, 259 (5093), 381-4. 
179. Chen, X.; Jhee, K. H.; Kruger, W. D., Production of the neuromodulator H2S by 
cystathionine beta-synthase via the condensation of cysteine and homocysteine. J Biol Chem 
2004, 279 (50), 52082-52086. 
180. Ishii, I.; Akahoshi, N.; Yu, X.; Kobayashi, Y.; Namekata, K.; Komaki, G.; Kimura, H., 
Murine cystathionine gamma-lyase: complete cDNA and genomic sequences, promoter activity, 
tissue distribution and developmental expression. Biochemical Journal 2004, 381, 113-123. 
181. Kamoun, P.; Belardinelli, M.-C.; Chabli, A.; Lallouchi, K.; Chadefaux-Vekemans, B., 
Endogenous hydrogen sulfide overproduction in down syndrom. Am. J. Med. Genet. 2003, 116A 
(3), 310-311. 
182. Chen, Y.; Yao, W.; Geng, B.; Ding, Y.; Lu, M.; Zhao, M.; Tang, C., Endogenous 
hydrogen sulfide in patients with COPD. Chest 2005, 128, 3205-3211. 
183. Lefer, D. J., A new gaseous signaling molecule emerges: Cardioprotective role of 
hydrogen sulfide. P. Natl. Acad. Sci. U. S. A. 2007, 104 (46), 17907-17908. 
184. Kimura, H., Hydrogen sulfide as a neuromodulator. Mol. Neurobiol. 2002, 26 (1), 13-19. 
185. Zhang, L.; Sio, S. W. S.; Moochhala, S.; Bhatia, M., Role of Hydrogen Sulfide in Severe 
Burn Injury-Induced Inflammation in Mice. Mol. Med. 2010, 16 (9-10), 417-424. 
186. Li, L.; Bhatia, M.; Zhu, Y. Z.; Zhu, Y. C.; Ramnath, R. D.; Wang, Z.; Anuar, F. B. M.; 
Whiteman, M.; Salto-Tellez, M.; Moore, P. K., Hydrogen sulfide is a novel mediator of 
lipopolysaccharide-induced inflammation in the mouse. FASEB J. 2005, 19 (6), 1196-1198. 
187. Martelli, A.; Testai, L.; Breschi, M. C.; Blandizzi, C.; Virdis, A.; Teddei, S.; Calderone, 
V., Hydrogen sulfide: novel oppotunity for drug discovery. Med. Res. Rev. 2011. 
110 
188. Vandiver, M. S.; Snyder, S. H., Hydrogen sulfide: a gasotransmitter of clinical relevance. 
J. Mol. Med. 2012, 90 (3), 255-263. 
189. Wei, L.; Dasgupta, P. K., Determination of sulfide and mercaptans in caustic scrubbing 
liquor. Anal Chim Acta 1989, 226 (1), 165-170. 
190. Doeller, J. E.; Isbell, T. S.; Benavides, G.; Koenitzer, J.; Patel, H.; Patel, R. P.; Lancaster, 
J. R.; Darley-Usmar, V. M.; Kraus, D. W., Polarographic measurement of hydrogen sulfide 
production and consumption by mammalian tissues. Anal Biochem 2005, 341 (1), 40-51. 
191. Schiavon, G.; Zotti, G.; Toniolo, R.; Bontempelli, G., Electrochemical detection of trace 
hydrogen-sulfide in gaseous samples by porous silver electrodes supported on ion-exchange 
membranes (solid polymer electrolytes). Anal Biochem 1995, 67 (2), 318-323. 
192. Ubuka, T.; Abe, T.; Kajikawa, R.; Morino, K., Determination of hydrogen sulfide and 
acid-labile sulfur in animal tissues by gas chromatography and ion chromatography. J 
Chromatogr B Biomed Sci Appl 2001, 757 (1), 31-37. 
193. Peng, H.; Chen, W.; Cheng, Y.; Hakuna, L.; Strongin, R.; Wang, B., Thiol reactive 
probes and chemosensors. Sensors 2012, 12 (11), 15907. 
194. Peng, H.; Chen, W.; Burroughs, S.; Wang, B., Fluorescent Probes for the Detection of 
Hydrogen Sulfide in Biological Systems. Curr. Org. Chem. 2013, 17 (13), 641-653. 
195. Xuan, W. M.; Sheng, C. Q.; Cao, Y. T.; He, W. H.; Wang, W., Fluorescent Probes for the 
Detection of Hydrogen Sulfide in Biological Systems. Angew. Chem. Int. Ed. 2012, 51 (10), 
2282-2284. 
196. Peng, H.; Cheng, Y.; Dai, C.; Wang, B., A fluorescent probe for fast and quantitative 
detection of hydrogen sulfide in blood. Angew. Chem. Int. Ed. 2011, 50 (41), 9672-9675. 
111 
197. Lippert, A. R.; New, E. J.; Chang, C. J., Reaction-based fluorescent probes for selective 
imaging of hydrogen sulfide in living cells. J. Am. Chem. Soc. 2011, 133 (26), 10078-10080. 
198. Liu, C.; Pan, J.; Li, S.; Zhao, Y.; Wu, L.; Berkman, C. E.; Whorton, A. R.; Xian, M., 
Capture and Visualization of Hydrogen Sulfide by a Fluorescent Probe. Angew. Chem. Int. Ed. 
2011, 50 (44), 10327-10329. 
199. Qian, Y.; Karpus, J.; Kabil, O.; Zhu, H.-L.; Banerjee, R.; Zhao, J.; He, C., Selective 
fluorescent probes for live-cell monitoring of sulfide. Nat. Commun. 2011, 2, 495. 
200. Liu, C.; Peng, B.; Li, S.; Park, C. M.; Whorton, A. R.; Xian, M., Reaction Based 
Fluorescent Probes for Hydrogen Sulfide. Org. Lett. 2012, 14 (8), 2184-2187. 
201. Qian, Y.; Zhang, L.; Ding, S.; Deng, X.; He, C.; Zhu, H.-L.; Zhao, J., A fluorescent probe 
for rapid detection of hydrogen sulfide in blood plasma and brain tissues in mice. Chem. Sci. 
2012, 3, 2920-2923. 
202. Xu, Z.; Xu, L.; Zhou, J.; Xu, Y. F.; Zhu, W. P.; Qian, X. H., A highly selective 
fluorescent probe for fast detection of hydrogen sulfide in aqueous solution and living cells. 
Chem. Commun. 2012, 48 (88), 10871-10873. 
203. Montoya, L. A.; Pluth, M. D., Selective turn-on fluorescent probes for imaging hydrogen 
sulfide in living cells. Chem. Commun. 2012, 48 (39), 4767-4769. 
204. Yu, F.; Li, P.; Song, P.; Wang, B.; Zhao, J.; Han, K., An ICT-based strategy to a 
colorimetric and ratiometric fluorescence probe for hydrogen sulfide in living cells. Chem. 
Commun. 2012, 48, 2852-2854. 
205. Das, S. K.; Lim, C. S.; Yang, S. Y.; Han, J. H.; Cho, B. R., A small molecule two-photon 
probe for hydrogen sulfide in live tissues. Chem. Commun. 2012, 48 (67), 8395-8397. 
112 
206. Chen, S.; Chen, Z.; Ren, W.; Ai, H., Reaction-Based Genetically Encoded Fluorescent 
Hydrogen Sulfide Sensors. J. Am. Chem. Soc. 2012, 134 (23), 9589-9592. 
207. Sasakura, K.; Hanaoka, K.; Shibuya, N.; Mikami, Y.; Kimura, Y.; Komatsu, T.; Ueno, T.; 
Terai, T.; Kimura, H.; Nagano, T., Development of a Highly Selective Fluorescence Probe for 
Hydrogen Sulfide. J. Am. Chem. Soc. 2011, 133 (45), 18003-18005. 
208. Choi, M. G.; Cha, S.; Lee, H.; Jeon, H. L.; Chang, S. K., Sulfide-selective 
chemosignaling by a Cu2+ complex of dipicolylamine appended fluorescein. Chem. Commun. 
2009,  (47), 7390-7392. 
209. Hou, F. P.; Huang, L.; Xi, P. X.; Cheng, J.; Zhao, X. F.; Xie, G. Q.; Shi, Y. J.; Cheng, F. 
J.; Yao, X. J.; Bai, D. C.; Zeng, Z. Z., A Retrievable and Highly Selective Fluorescent Probe for 
Monitoring Sulfide and Imaging in Living Cells. Inorg. Chem. 2012, 51 (4), 2454-2460. 
210. Lin, V.; Chang, C., Fluorescent probes for sensing and imaging biological hydrogen 
sulfide. Curr Opin Chem Biol 2012, 16 (5-6), 595-601. 
211. Pandey, S. K.; Kim, K. H.; Tang, K. T., A review of sensor-based methods for 
monitoring hydrogen sulfide. TrAC, Trends Anal Chem 2012, 32, 87-99. 
212. Peng, H.; Chen, W.; Cheng, Y.; Hakuna, L.; Strongin, R.; Wang, B., Thiol reactive 
probes and chemosensors. Sensors (Basel) 2012, 12 (11), 15907-15946. 
213. Peng, H.; Chen, W.; Burroughs, S.; Wang, B., Recent advances in fluorescent probes for 
the detection of hydrogen sulfide. Curr. Org. Chem. 2013, 17 (6), 641-653. 
214. Liu, T.; Xu, Z.; Spring, D.; Cui, J., A lysosome-targetable fluorescent probe for imaging 
hydrogen sulfide in living cells. Org Lett 2013, 15 (9), 2310-2313. 
113 
215. Chen, Y.; Zhu, C.; Yang, Z.; Chen, J.; He, Y.; Jiao, Y.; He, W.; Qiu, L.; Cen, J.; Guo, Z., 
A ratiometric fluorescent probe for rapid detection of hydrogen sulfide in mitochondria. Angew 
Chem Int Ed 2013, 52 (6), 1688-1691. 
216. Lutolf, M.; Tirelli, N.; Cerritelli, S.; Cavalli, L.; Hubbell, J., Systematic modulation of 
Michael-type reactivity of thiols through the use of charged amino acids. Bioconjugate Chem 
2001, 12 (6), 1051-1056. 
217. Liu, J.; Sun, Y.-Q.; Zhang, J.; Yang, T.; Cao, J.; Zhang, L.; Guo, W., A ratiometric 
fluorescent probe for biological signaling molecule H2S: fast response and high selectivity. 
Chem Eur J 2013, 19 (15), 4717-4722. 
218. Wang, X.; Sun, J.; Zhang, W.; Ma, X.; Lv, J.; Tang, B., A near-infrared ratiometric 
fluorescent probe for rapid and highly sensitive imaging of endogenous hydrogen sulfide in 
living cells. Chem Sci 2013, 4, 2551-2556. 
219. Wang, J.; Lin, W.; Li, W., Three-channel fluorescent sensing via organic white light-
emitting dyes for detection of hydrogen sulfide in living cells. Biomaterials 2013, 34, 7429-
7436. 
220. Qian, Y.; Karpus, J.; Kabil, O.; Zhang, S.; Zhu, H.; Banerjee, R.; Zhao, J.; He, C., 
Selective fluorescent probes for live-cell monitoring of sulphide. Nat. Commun. 2011, 2, 495. 
221. Yong, Q.; Ling, Z.; Shuting, D.; Xin, D.; Chuan, H.; Xi Emily, Z.; HaiLiang, Z.; Jing, Z., 
A fluorescent probe for rapid detection of hydrogen sulfide in blood plasma and brain tissues in 
mice. Chem. Sci. 2012, 3. 
222. Lin, V.; Lippert, A.; Chang, C., Cell-trappable fluorescent probes for endogenous 
hydrogen sulfide signaling and imaging H2O2-dependent H2S production. Proc Natl Acad Sci 
U. S. A. 2013, 110 (18), 7131-7135. 
114 
223. Bae, S. K.; Heo, C. H.; Choi, D. J.; Sen, D.; Joe, E. H.; Cho, B. R.; Kim, H. M., A 
ratiometric two-photon fluorescent probe reveals reduction in mitochondrial H2S production in 
parkinson's disease gene knockout astrocytes. J Am Chem Soc 2013, 135 (26), 9915-9923. 
224. Wang, B.; Li, P.; Yu, F.; Song, P.; Sun, X.; Yang, S.; Lou, Z.; Han, K., A reversible 
fluorescence probe based on Se-BODIPY for the redox cycle between HClO oxidative stress and 
H2S repair in living cells. Chem Commun 2013, 49 (10), 1014-1016. 
225. Wang, B.; Li, P.; Yu, F.; Chen, J.; Qu, Z.; Han, K., A near-infrared reversible and 
ratiometric fluorescent probe based on Se-BODIPY for the redox cycle mediated by 
hypobromous acid and hydrogen sulfide in living cells. Chem Commun 2013, 49 (51), 5790-
5792. 
226. Xuan, W.; Pan, R.; Cao, Y.; Liu, K.; Wang, W., A fluorescent probe capable of detecting 
H2S at submicromolar concentrations in cells. Chem Commun 2012, 48 (86), 10669-10671. 
227. Chen, S.; Chen, Z.; Ren, W.; Ai, H., Reaction-based genetically encoded fluorescent 
hydrogen sulfide sensors. J Am Chem Soc 2012, 134 (23), 9589-9592. 
228. Li, Y.-H.; Chan, L.-M.; Tyer, L.; Moody, R. T.; Hirnel, C. M.; Hercules, D. M., Study of 
solvent effects on the fluorescence of 1-(dimethylamino)-5-naphthalenesulfonic acid and related 
compounds. J. Am. Chem. Soc. 1975, 97 (11), 3118-3126. 
229. Williams, A. T. R.; Winfield, S. A.; Miller, J. N., Relative fluorescence quantum yields 
using a computer-controlled luminescence spectrometer. Analyst 1983, 108 (1290), 1067-1071. 
230. Fava, A.; Iliceto, A.; Camera, E., Kinetics of the thiol/disulfide exchange. J Am Chem 
Soc 1956, 70, 833-838. 
231. Go, Y. M.; Jones, D. P., Thiol/disulfide redox states in signaling and sensing. Crit Rev 
Biochem Mol Biol 2013, 48 (2), 173-181. 
115 
232. Deneke, S. M., Thiol-based antioxidants. Curr Top Cell Regul 2000, 36, 151-180. 
233. Murphy, M., Mitochondrial thiols in antioxidant protection and redox signaling: distinct 
roles for glutathionylation and other thiol modifications. Antioxid Redox Signaling 2012, 16 (6), 
476-495. 
234. Chen, N.; Yang, F.; Capecci, L. M.; Gu, Z.; Schafer, A. I.; Durante, W.; Yang, X.; Wang, 
H., Regulation of homocysteine metabolism and methylation in human and mouse tissues. 
FASEB J. 2010, 24 (8), 2804-2817. 
235. Selhub, J., Homocysteine metabolism. Annu. Rev. Nutr. 1999, 19, 217-246. 
236. Ueland, P. M., Homocysteine Species as Components of Plasma Redox Thiol Status. 
Clin. Chem. 1995, 41 (3), 340-342. 
237. Chambers, J. C.; Ueland, P. M.; Wright, M.; Dore, C. J.; Refsum, H.; Kooner, J. S., 
Investigation of relationship and protein-bound homocysteine between reduced, oxidized, and 
vascular endothelial function in healthy human subjects. Circ. Res. 2001, 89 (2), 187-192. 
238. Clarke, R.; Smith, A. D.; Jobst, K. A.; Refsum, H.; Sutton, L.; Ueland, P. M., Folate, 
vitamin B-12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 
1998, 55 (11), 1449-1455. 
239. Falk, E.; Zhou, J.; Møller, J., Homocysteine and atherothrombosis. Lipids 2001, 36, 3-11. 
240. Fung, T.; Rimm, E.; Spiegelman, D.; Rifai, N.; Tofler, G.; Willett, W.; Hu, F., 
Association between dietary patterns and plasma biomarkers of obesity and cardiovascular 
disease risk. Am J Clin Nutr 2001, 73 (1), 61-67. 
241. Miller, J. W.; Nadeau, M. R.; Smith, J.; Smith, D.; Selhub, J., Homocysteinemia - a 
consequence of disrupting S-adenosylmethionines regulation of homocysteine metabolism. 
FASEB J. 1992, 6 (4), A1215-A1215. 
116 
242. Makino, A.; Nakanishi, T.; Sugiura-Ogasawara, M.; Ozaki, Y.; Suzumori, N.; Suzumori, 
K., No association of C677T methylenetetrahydrofolate reductase and an endothelial nitric oxide 
synthase polymorphism with recurrent pregnancy loss. Am J Reprod Immunol 2004, 52 (1), 60-
66. 
243. Ebbing, M.; Bønaa, K.; Arnesen, E.; Ueland, P.; Nordrehaug, J.; Rasmussen, K.; 
Njølstad, I.; Nilsen, D.; Refsum, H.; Tverdal, A.; Vollset, S.; Schirmer, H.; Bleie, Ø.; Steigen, T.; 
Midttun, Ø.; Fredriksen, A.; Pedersen, E.; Nygård, O., Combined analyses and extended follow-
up of two randomized controlled homocysteine-lowering B-vitamin trials. J Intern Med 2010, 
268 (4), 367-382. 
244. Malinow, M. R.; Bostom, A. G.; Krauss, R. M., Homocyst(e)ine, diet, and cardiovascular 
diseases - A statement for healthcare professionals from the Nutrition Committee, American 
Heart Association. Circulation 1999, 99 (1), 178-182. 
245. Chen, X.; Zhou, Y.; Peng, X.; Yoon, J., Fluorescent and colorimetric probes for detection 
of thiols. Chem Soc Rev 2010, 39 (6), 2120-2135. 
246. Janáky, R.; Varga, V.; Hermann, A.; Saransaari, P.; Oja, S., Mechanisms of L-cysteine 
neurotoxicity. Neurochem Res 2000, 25 (9-10), 1397-1405. 
247. Martin, H. L.; Teismann, P., Glutathione-a review on its role and significance in 
Parkinson's disease. Faseb Journal 2009, 23 (10), 3263-3272. 
248. Jocelyn, P. C., The standard redox potential of cysteine-cystine from the thiol-disulphide 
exchange reaction with glutathione and lipoic acid Eur J Biochem 1967, 2 (3), 327-331. 
249. Sanadi, D. R.; Langley, M.; Searls, R. L., α-Ketoglutaric dehydrogenase: VI. reversible 
oxidation of dihydrothioctamide by diphosphopyridine nucleotide. J Biol Chem 1959, 234, 178-
182. 
117 
250. Escobedo, J.; Rusin, O.; Wang, W.; Alptürk, O.; Kim, K.; Xu, X.; Strongin, R., Detection 
of Biological Thiols. In Reviews in Fluorescence 2006, Geddes, C.; Lakowicz, J., Eds. Springer 
US: 2006; Vol. 2006, pp 139-162. 
251. Refsum, H.; Smith, A.; Ueland, P.; Nexo, E.; Clarke, R.; McPartlin, J.; Johnston, C.; 
Engbaek, F.; Schneede, J.; McPartlin, C.; Scott, J., Facts and recommendations about total 
homocysteine determinations: an expert opinion. Clin Chem 2004, 50 (1), 3-32. 
252. Burns, J. A.; Butler, J. C.; Moran, J.; Whitesides, G. M., Selective reduction of disulfides 
by tris(2-carboxyethyl)phosphine. J Org Chem 1991, 56, 2648-2650. 
253. Mendel, F.; Cavins, J. F.; Wall, J. S., Relative nucleophilic reactivities of amino groups 
and mercaptide ions in addition reactions with α, β-unsaturated compounds. J Am Chem Soc 
1965, 87. 
254. Lai, Y.; Tseng, W., Gold nanoparticle extraction followed by o-phthaldialdehyde 
derivatization for fluorescence sensing of different forms of homocysteine in plasma. Talanta 
2012, 91, 103-109. 
255. Wang, W.; Escobedo, J.; Lawrence, C.; Strongin, R., Direct detection of homocysteine. J 
Am Chem Soc 2004, 126 (11), 3400-3401. 
256. Ueland, P. M.; Refsum, H.; Stabler, S. P.; Malinow, M. R.; Andersson, A.; Allen, R. H., 
Total Homocysteine in Plasma or Serum - Methods and Clinical-Applications. Clin. Chem. 1993, 
39 (9), 1764-1779. 
257. Kusmierek, K.; Glowacki, R.; Bald, E., Analysis of urine for cysteine, cysteinylglycine, 
and homocysteine by high-performance liquid chromatography. Anal. Bioanal. Chem. 2006, 385 
(5), 855-860. 
118 
258. Chen, X.; Zhou, Y.; Peng, X. J.; Yoon, J., Fluorescent and colorimetric probes for 
detection of thiols. Chem. Soc. Rev. 2010, 39 (6), 2120-2135. 
259. Xiong, L.; Zhao, Q.; Chen, H.; Wu, Y.; Dong, Z.; Zhou, Z.; Li, F., Phosphorescence 
imaging of homocysteine and cysteine in living cells based on a cationic iridium(III) complex. 
Inorg Chem 2010, 49 (14), 6402-6408. 
260. Wang, W.; Rusin, O.; Xu, X.; Kim, K.; Escobedo, J.; Fakayode, S.; Fletcher, K.; Lowry, 
M.; Schowalter, C.; Lawrence, C.; Fronczek, F.; Warner, I.; Strongin, R., Detection of 
homocysteine and cysteine. J Am Chem Soc 2005, 127 (45), 15949-15958. 
261. Lu, C.; Zu, Y., Specific detection of cysteine and homocysteine: recognizing one-
methylene difference using fluorosurfactant-capped gold nanoparticles. Chem Commun 2007,  
(37), 3871-3873. 
262. Chwatko, G.; Jakubowski, H., The determination of homocysteine-thiolactone in human 
plasma. Anal Biochem 2005, 337 (2), 271-277. 
263. Chen, H.; Zhao, Q.; Wu, Y.; Li, F.; Yang, H.; Yi, T.; Huang, C., Selective 
phosphorescence chemosensor for homocysteine based on an iridium(III) complex. Inorg. Chem. 
2007, 46 (26), 11075-11081. 
264. Yang, X.; Guo, Y.; Strongin, R. M., Conjugate addition/cyclization sequence enables 
selective and simultaneous fluorescence detection of cysteine and homocysteine. Angew. Chem. 
Int. Ed. 2011, 50 (4), 10690-10693. 
265. Guo, Z.; Nam, S.; Park, S.; Yoon, J., A highly selective ratiometric near-infrared 
fluorescent cyanine sensor for cysteine with remarkable shift and its application in bioimaging. 
Chem. Sci. 2012, 3, 2760-2765. 
119 
266. Peng, H.; Chen, W.; Cheng, Y.; Hakuna, L.; Strongin, R.; Wang, B., Thiol Reactive 
Probes and Chemosensors. Sensors 2012, 12 (11), 15907-15946. 
267. Wang, K.; Peng, H.; Wang, B., Recent Advances in Thiol and Sulfide Reactive Probes. J. 
Cell. Biochem. 2014, 115 (6), 1007-1022. 
268. Strongin, R. M.; Wang, W. H.; Escobedo, J. O.; Lawrence, C. M., Direct detection of 
homocysteine. J. Am. Chem. Soc. 2004, 126 (11), 3400-3401. 
269. Rusin, O.; Wang, W. H.; Xu, X. Y.; Kim, K. K.; Escobedo, J. O.; Fakayode, S. O.; 
Fletcher, K. A.; Lowry, M.; Schowalter, C. M.; Lawrence, C. M.; Fronczek, F. R.; Warner, I. M.; 
Strongin, R. M., Detection of homocysteine and cysteine. J. Am. Chem. Soc. 2005, 127 (45), 
15949-15958. 
270. Escobedo, J. O.; Wang, W. H.; Strongin, R. M., Use of a commercially available reagent 
for the selective detection of homocysteine in plasma. Nat. Protoc. 2006, 1 (6), 2759-2762. 
271. Hakuna, L.; Escobedo, J. O.; Lowry, M.; Barve, A.; McCallum, N.; Strongin, R. M., A 
photochemical method for determining plasma homocysteine with limited sample processing. 
Chem. Commun. 2014, 50 (23), 3071-3073. 
272. Lee, H. Y.; Choi, Y. P.; Kim, S.; Yoon, T.; Guo, Z.; Lee, S.; Swamy, K. M. K.; Kim, G.; 
Lee, J. Y.; Shin, I.; Yoon, J., Selective homocysteine turn-on fluorescent probes and their 
bioimaging applications. Chem. Commun. 2014, 50, 6967-6969. 
273. Peng, H.; Cheng, Y.; Dai, C.; King, A. L.; Predmore, B. L.; Lefer, D. J.; Wang, B., A 
fluorescent probe for fast and quantitative detection of hydrogen sulfide in blood. Angew. Chem. 
Int. Ed. 2011, 50 (41), 9672-9675. 
274. Ellman, G. L., Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959, 82 (1), 70-77. 
120 
275. Hogg, N., The effect of cyst(e)ine on the auto-oxidation of homocysteine. Free Radical 
Bio.Med. 1999, 27 (1-2), 28-33. 
276. Gabaldon, M., Oxidation of cysteine and homocysteine by bovine albumin. Arch. 
Biochem. Biophys. 2004, 431 (2), 178-188. 
277. O'Connor, N. A.; Sakata, S. T.; Zhu, H.; Shea, K. J., Chemically modified dansyl probes: 
A fluorescent diagnostic for ion and proton detection in solution and in polymers. Org. Lett. 
2006, 8 (8), 1581-1584. 
278. Jones, D.; Carlson, J.; Samiec, P.; Sternberg, P.; Mody, V.; Reed, R.; Brown, L., 
Glutathione measurement in human plasma: evaluation of sample collection, storage and 
derivatization conditions for analysis of dansyl derivatives by HPLC. Clin. Chim. Acta 1998. 
279. Wang, K.; Peng, H.; Ni, N.; Dai, C.; Wang, B., 2,6-Dansyl azide as a fluorescent probe 
for hydrogen sulfide. J. Fluoresc. 2013, 24 (1), 1-5. 
280. Friedman, M.; Cavins, J. F.; Wall, J. S., Relative nucleophilic reactivities of amino 
groups and mercaptide ions in addition reactions with ,-unsaturated compounds. J. Am. Chem. 
Soc. 1965, 87 (16), 3672-3682. 
281. Pitman, I. H.; Morris, I. J., Covalent Additions of Glutathione, Cysteine, Homocysteine, 
Cysteamine and Thioglycolic Acid to Quinazoline Cation. Aust. J. Chem. 1979, 32 (7), 1567-
1573. 
282. Benesch, R. E.; Benesch, R., The Acid Strength of the -Sh Group in Cysteine and Related 
Compounds. J. Am. Chem. Soc. 1955, 77 (22), 5877-5881. 
283. Cao, X. W.; Lin, W. Y.; Yu, Q. X., A Ratiometric Fluorescent Probe for Thiols Based on 
a Tetrakis (4-hydroxyphenyl)porphyrin-Coumarin Scaffold. J. Org. Chem. 2011, 76 (18), 7423-
7430. 
121 
284. Scampicchio, M.; Lawrence, N. S.; Arecchi, A.; Mannino, S., Electrochemical reduction 
of Ellman's reagent: A novel selective detection protocol for thiol compounds. Electroanalysis 
2007, 19 (23), 2437-2443. 
285. Iciek, M.; Chwatko, G.; Lorenc-Koci, E.; Bald, E.; Wlodek, L., Plasma levels of total, 
free and protein bound thiols as well as sulfane sulfur in different age groups of rats. Acta 
Biochim. Pol. 2004, 51 (3), 815-824. 
286. Cartwright, I. L.; Hutchinson, D. W.; Armstrong, V. W., The reaction between thiols and 
8-azidoadenosine derivatives. Nucleic Acids Res. 1976, 3 (9), 2331-2340. 
287. Kerr, J. A., In CRC Handbook of Chemistry and Physics 1999-2000 : A Ready-Reference 
Book of Chemical and Physical Data (CRC Handbook of Chemistry and Physics, D.R. Lide, 
(ed.), 81st edition ed.; CRC Press: Boca Raton, Florida, USA, 2000. 
288. Bao, M.; Shimizu, M., N-Trifluoroacetyl arenesulfenamides, effective precursors for 
synthesis of unsymmetrical disulfides and sulfenamides. Tetrahedron 2003, 59, 9655-9659. 
 
 
 
 
 
 
 
 
 
 
1 
APPENDICES  
Appendix A Spectra of compounds and DNA products in DNA modification 
Appendix A.1 Spectra of Synthesized Compounds 
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Appendix A.2 MALDI-TOF Spectra of DNA Products 
 
MALDI-TOF spectrum of TCO-DNA21 (Template-1) 
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MALDI-TOF spectrum of TCO-DNA21 (Template-1) after reacting with Tz-BBA 
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MALDI-TOF spectrum of dNTP-DNA21 (Template-1) after reacting with Tz-BBA 
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Appendix B Spectra of compounds in hydrogen sulfide probe 
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Appendix C Spectra of compounds in homocysteine probe
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